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Abstract
Innate immunity is the first line of defense against viral infection and depends on the use of germlineencoded pattern recognition receptors (PRRs) that detect pathogen-associated molecular patterns
(PAMPs). Virus recognition subsequently triggers an assortment of effector responses that are critical for
clearing the invading pathogen. Among known antiviral pathways, autophagy, a biological process that
mediates the degradation of cytoplasmic components, may be one of the most ancient. We previously
demonstrated that autophagy is essential for resistance to the Rhabdovirus Vesicular stomatitis virus
(VSV) in flies. However, the mechanism by which autophagy is triggered during VSV infection remained
unclear. Through a targeted RNAi screen, I discovered that a previously uncharacterized Drosophila Toll
receptor, Toll-7, is essential for restricting VSV replication in cells and adult flies. Moreover, Toll-7 was
required to activate antiviral autophagy both in vitro and in vivo. Toll-7 interacted with VSV virions at the
cell surface, demonstrating that Toll-7 is a bona fide PRR and the only known Toll receptor that physically
associates with a pathogen. Taken together, these data have revealed Toll-7 as the link between VSV
recognition and activation of antiviral autophagy.
To investigate the range of Toll receptor-mediated antiviral immunity, I next challenged Toll receptor
mutant flies with a panel of arthropod-borne viruses (arboviruses). These studies revealed a critical in
vivo role for Toll-7 in restricting infection with Rift Valley fever virus (RVFV), a medically relevant pathogen
in the bunyavirus family that causes disease in humans and livestock. Toll-7 mutant flies showed
increased viral replication and mortality after RVFV infection due to impaired antiviral autophagy
activation. Remarkably, autophagy was also required to restrict RVFV infection in mouse and human cells,
demonstrating an evolutionarily conserved role for antiviral autophagy in flies and mammals. Autophagy
activation using pharmacologic inducers of autophagy potently inhibited RVFV infection in flies and
mammalian cells. Collectively, these data suggest that modulation of this conserved antiviral pathway
may be a promising strategy for controlling RVFV infection, which lacks effective therapeutics and
vaccines, in both mammals and the vector insect.
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ABSTRACT

AN EVOLUTIONARILY CONSERVED ROLE FOR
AUTOPHAGY IN ANTIVIRAL DEFENSE

Ryan H. Moy
Sara Cherry

Innate immunity is the first line of defense against viral infection and depends on
the use of germline-encoded pattern recognition receptors (PRRs) that detect pathogenassociated molecular patterns (PAMPs). Virus recognition subsequently triggers an
assortment of effector responses that are critical for clearing the invading pathogen.
Among known antiviral pathways, autophagy, a biological process that mediates the
degradation of cytoplasmic components, may be one of the most ancient. We previously
demonstrated that autophagy is essential for resistance to the Rhabdovirus Vesicular
stomatitis virus (VSV) in flies. However, the mechanism by which autophagy is triggered
during VSV infection remained unclear. Through a targeted RNAi screen, I discovered
that a previously uncharacterized Drosophila Toll receptor, Toll-7, is essential for
restricting VSV replication in cells and adult flies. Moreover, Toll-7 was required to
activate antiviral autophagy both in vitro and in vivo. Toll-7 interacted with VSV virions at
the cell surface, demonstrating that Toll-7 is a bona fide PRR and the only known Toll
receptor that physically associates with a pathogen. Taken together, these data have
revealed Toll-7 as the link between VSV recognition and activation of antiviral
autophagy.
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To investigate the range of Toll receptor-mediated antiviral immunity, I next
challenged Toll receptor mutant flies with a panel of arthropod-borne viruses
(arboviruses). These studies revealed a critical in vivo role for Toll-7 in restricting
infection with Rift Valley fever virus (RVFV), a medically relevant pathogen in the
bunyavirus family that causes disease in humans and livestock. Toll-7 mutant flies
showed increased viral replication and mortality after RVFV infection due to impaired
antiviral autophagy activation. Remarkably, autophagy was also required to restrict
RVFV infection in mouse and human cells, demonstrating an evolutionarily conserved
role for antiviral autophagy in flies and mammals. Autophagy activation using
pharmacologic inducers of autophagy potently inhibited RVFV infection in flies and
mammalian cells. Collectively, these data suggest that modulation of this conserved
antiviral pathway may be a promising strategy for controlling RVFV infection, which lacks
effective therapeutics and vaccines, in both mammals and the vector insect.
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I. INTRODUCTION 1
1. Pathogen Recognition and Innate Immunity
Eukaryotic organisms are constantly exposed to potential microbial insults, and
thus they require effective mechanisms to recognize and eliminate pathogens. The
innate immune system provides the first line of defense against such invaders, acting
nearly instantaneously at the time of infection (214). In mammals, the innate immune
system often helps control the infection before the acquired immune system reaches
maximal activation, but some organisms such as insects rely entirely on the innate
system for host defense (107). Recognition of pathogens by the innate immune system
depends on germline-encoded protein sensors known as pattern recognition receptors
(PRRs), which detect broadly conserved microbe-derived molecules known as
pathogen-associated molecular patterns (PAMPs). These PAMPs are often essential
such that they cannot be discarded by the pathogen, i.e. viral nucleic acids or bacterial
cell wall components. In this way, organisms are able to rapidly respond to and destroy a
diverse spectrum of foreign pathogens.
Toll-like receptors (TLRs) represent the canonical family of PRRs in metazoans
and were first identified in Drosophila (124). Located at the cell surface or in endosomal
compartments, these receptors are type-I transmembrane proteins that contain
extracellular leucine-rich repeat (LRR) motifs and an intracellular Toll/interleukin-1
receptor (TIR) domain (203). The founding member of this PRR family, Drosophila Toll
(Toll-1), was originally appreciated for its role in embryonic development and the
establishment of dorsal-ventral polarity (5). Landmark findings in the mid 1990s,
1. Portions of this chapter were reprinted from Moy, R.H., and S. Cherry. 2013. Antimicrobial
autophagy: a conserved innate immune response in Drosophila. J Innate Immunity 5: 444455, with permission from Karger.
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however, demonstrated that Toll was not just involved in development but was also
critical for host immunity (122, 123). Toll and the associated signaling cassette were
required for the induction of antimicrobial peptides (AMPs) in response to fungal and
bacterial infection. These observations led to the cloning of the human TLRs and the
finding that mouse TLR4 is the sensor for lipopolysaccharide (LPS) that controls the
endotoxin-induced inflammatory response (143, 169). There are 10 human TLRs and 12
murine TLRs, and the ligands for these receptors have been extensively characterized.
For example, viruses can be recognized by TLR3, TLR7 and TLR9, which detect viral
double-stranded RNA (dsRNA), single-stranded RNA (ssRNA) and unmethylated CpG
DNA, respectively, as well as other TLRs such as TLR2 and TLR4 that can sense viral
glycoproteins (10). In contrast, flies have nine Toll receptors whose ligands and
functions in immunity have not been fully established, with the exception of Toll-1 (61).
While TLRs act in endosomes or at the cell surface, other PRRs such as the
retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) survey the cytoplasm for viral
nucleic acids (132). There are two RLRs in humans and mice: RIG-I and melanoma
differentiation associated factor 5 (MDA-5). These proteins consist of an N-terminal
caspase activation and recruitment domain (CARD), a core DEAD-box helicase domain
and a C-terminal repressor domain. RIG-I preferentially recognizes short dsRNA as well
as dsRNA containing a 5’-triphosphate group, whereas MDA-5 seems to favor long
dsRNA (78, 104). While model ligands for these RLRs have been defined, the exact viral
nucleic acid species directly recognized during infection are not well-understood, as
certain viruses are detected by RIG-I but not MDA-5, and vice versa. Interestingly,
invertebrates such as flies do not encode homologs of the RLRs, although the protein
Dicer-2 controls antiviral transcriptional responses and may represent a functional
equivalent (48).
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In addition to these receptor families, several other types of PRRs exist, including
the NOD-like receptors (NLRs), inflammasomes, DNA sensors, protein kinase R (PKR),
etc. Together, these receptors link pathogen recognition to the activation of effector
responses responsible for eliminating invading pathogens and preventing lethality due to
infection. While the range of PRRs can vary between organisms, the extensive
evolutionary history of the innate immune system suggests that many types of innate
responses are deeply conserved across species. Thus, studies in model organisms such
as Drosophila can reveal critical insights into the origins of host defense pathways and
have significant relevance to human immunity and the treatment of infectious disease.

2. Drosophila as a Model for Studying Innate Immunity against Arboviruses
Arthropod-borne viruses (arboviruses) represent a major threat to human health
and pose a significant global economic burden. Arboviruses are transmitted by
hematophagous (blood feeding) insect vectors such as a mosquitoes, ticks or biting flies,
and circulate among wild animals with incidental spillover to human and domestic animal
populations (222). The vector insect typically acquires the virus via horizontal
transmission through the ingestion of a viremic bloodmeal from an infected animal. After
infecting the alimentary tract and disseminating, the virus replicates to high levels in the
salivary gland and is passed to a vertebrate host through the saliva during blood feeding.
Birds are the most common vertebrate host and serve as an important viral reservoir as
they are typically asymptomatic, whereas humans and ruminants usually do not transmit
the virus back to the vector and often manifest clinical disease. However, some
arboviruses such as Dengue virus (DENV) and Chikungunya virus (CHIKV) have
adapted to the human host and lost the requirement for an enzootic cycle, causing
extensive epidemics in tropical urban centers (223).
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There are three major classes of arboviruses that are medically relevant to
humans: the alphaviruses, the flaviviruses and the bunyaviruses (223). Collectively,
these viruses represent current or emerging human and veterinary threats worldwide.
For example, the flavivirus DENV is one of the most important human arboviral
pathogens with approximately 50-100 million cases yearly, including tens-of-thousands
of cases of dengue hemorrhagic fever/shock syndrome, which is sometimes lethal (195,
223). The emergence of this virus is tightly linked to tropical urbanization and the
colonization of these cities with mosquito vectors that live in close association with
humans (i.e. Aedes aegypti and Aedes albopictus). Another important human pathogen
is Rift Valley fever virus (RVFV), a member of the bunyavirus family that has caused
sporadic epidemics primarily in East Africa and the Saudi Arabian peninsula (89, 219).
Humans can be infected by mosquito bites or contact with infected livestock. Although
infection generally causes a self-limiting illness, a small percentage of patients (1-3%)
develop severe manifestations such as hepatitis, meningoencephalitis and hemorrhagic
fever (90). The agricultural burden of RVFV is also quite substantial, as the virus causes
an approximately 100% spontaneous abortion rate in infected livestock, and nearly all
infected neonates succumb to infection. Moreover, RVFV can potentially be weaponized
and is classified as a Category A high priority pathogen by the National Institute for
Allergy and Infectious Diseases. Importantly, there is a dearth of effective antiviral
therapeutics and vaccines for RVFV, DENV and other arboviral pathogens, necessitating
additional insights into the immunologic control of the virus in both the insect vector and
the mammalian host for the development of new treatment strategies.
To identify novels genes and pathways involved in innate immunity against
arboviruses, we have employed the fruit fly Drosophila melanogaster as a model system,
which provides several advantages. First, compared to mammals, flies have limited
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genetic redundancy and therefore deficiency of a single gene is more likely to reveal a
phenotype. Second, many powerful genetic tools are readily available in Drosophila.
Silencing of individual genes by RNA interference (RNAi) can be performed in
Drosophila cells without the requirement for transfection reagents, which has facilitated
the completion of genome-wide RNAi screens (38). RNAi is also achievable in vivo
through the GAL4-UAS transgenic fly system, and many mutant fly lines are
commercially available (84). Third, the developmental time of flies is greatly shortened
compared to mammalian models, with the average lifespan of Drosophila approximately
one month in length. Fourth, flies and mammals share significant immune biology with
both cellular and humoral immune systems (40, 112, 121). For example, flies contain
hematopoietic cells such as hemocytes that phagocytose and encapsulate foreign
pathogens, similar to mammalian macrophages. There are also many signaling
pathways implicated in immunity that are conserved between flies and mammals, such
as the NFκB, Jak-STAT and ERK pathways (180, 233). Finally, flies lack an adaptive
immune system, and thus we can study innate immunity against viral pathogens without
additional complexity added by adaptive immunity. Because of significant conservation
across species, findings from the Drosophila model can then be applied to related insect
vectors such as mosquitoes, as well as humans.
Models for several viral infections have been successfully established in
Drosophila. Flies are naturally infected by multiple RNA viruses, which are general
pathogenic for the organism, such as Drosophila C virus (DCV) and Flockhouse virus
(FHV) (86). These virus models have been used to demonstrate critical immune
functions for RNAi and other pathways in restricting viral replication, as well as to identify
host factors that are required for pathogenesis (39, 215). In addition, flies can be
infected with experimental pathogens that do not infect flies in the wild but nevertheless

5

replicate in the organism. While these viruses are often times not lethal in wild-type flies,
they provide an excellent opportunity to discover novel virus restriction factors, as loss of
a critical antiviral gene will convert a non-pathogenic infection to a pathogenic one. For
instance, we have developed in vitro and in vivo Drosophila models with the
Rhabdovirus Vesicular stomatitis virus (VSV) (188), the alphavirus Sindbis virus (SINV)
and the bunyavirus RVFV (63). These established experimental models have led to
important discoveries regarding immune signaling pathways and antiviral effector
responses in the fly and in humans, as well as host factors that are essential for
promoting viral infection.

3. Antimicrobial Immune Signaling Pathways in the Fly
The Drosophila immune repertoire against specific pathogens depends on
several conserved signaling pathways. Of these, two pathways that bear striking
similarities to the mammalian NFκB pathway have been extensively characterized,
particularly in bacterial and fungal infection: the Toll pathway and the IMD pathway.
Activation of these pathways upon pathogen recognition leads to the upregulation of
antimicrobial peptides (AMPs) that comprise the humoral immune system of the fly
(121). More recently, emerging evidence has also implicated these pathways and other
evolutionarily conserved signaling cascades in antiviral defense.
Originally appreciated for its role in dorsal-ventral patterning of the Drosophila
embryo (5), the Toll pathway plays a critical role in resistance to Gram-positive bacteria
and fungal pathogens. Seminal studies demonstrated that adult flies deficient in the
transmembrane receptor Toll, as well as known upstream and downstream signaling
components, are hypersusceptible to Aspergillus fumigatus (122). These findings soon
led to the identification of the mammalian TLRs, which collectively represent the
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canonical pattern recognition system in metazoans (203). Like the mammalian TLRs,
Drosophila Toll contains an extracellular domain consisting of LRR motifs and an
intracellular TIR domain (124). Interestingly, however, Toll does not recognize
pathogens directly but instead binds to the host cytokine spätzle, which is activated via
upstream PRRs that sense conserved constituents of bacterial and fungal cell walls
(224). For example, peptidoglycan (PGN) recognition protein (PGRP)-SA and Gramnegative binding protein 1 (GNBP1) detect the lysine (Lys)-type PGN of Gram-positive
bacteria (68, 144), whereas GNBP3 binds to yeast β-glucan (70). Pathogen recognition
triggers a serine protease cascade that converts the inactive spätzle precursor into the
active form that binds Toll (129). The ligation of Toll subsequently activates a signaling
cascade that depends on the TIR adapter MyD88, which converges on the nuclear
translocation of the transcription factors Dif and Dorsal (208). These Rel-like proteins
mediate transcription of AMP genes such as Drosomycin, which are critical for clearing
the infection.
While Toll has been most widely studied in the context of bacterial and fungal
infection, some data indicate that it may also have a role in controlling viral infection in
insects. For instance, DENV induces the Toll pathway in mosquitoes, and modulation of
Toll pathway components impacts viral replication (230). A similar role for the Toll
pathway in restricting viral infection was shown for Drosophila X virus (DXV) in flies,
while Toll was dispensable for controlling DCV infection (244). Whether the classical Toll
pathway has a broader role in antiviral defense is not known.
In addition to Toll, flies encode eight other Toll receptors, although their functions
are poorly characterized (124, 207). One study proposed that Toll-2 (18-wheeler) also
mediates the humoral immune response, as Toll-2 mutants demonstrated increased
susceptibility to bacterial challenge and reduced AMP gene induction (227). However, a
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later study re-examined the role of Toll-2 in bacterial infection, showing that adult Toll-2
mutant flies had no impairment in AMP expression, and that earlier findings may have
been due to the effect of Toll-2 loss on fat body development (128). Moreover, Toll-9
overexpression elicited Drosomycin expression in vitro but was dispensable for AMP
expression and resistance to bacterial infection in vivo (153, 160). Recent studies also
suggest that Toll-8 (Tollo) acts as a negative regulator of AMP expression in the larval
dorsal trachea, but whether this function has any impact on pathogen restriction has not
been evaluated (2). Finally, unlike mammalian TLRs, several Tolls may have important
requirements in embryonic development and cell migration, which has complicated our
understanding of their immune functions in the adult fly (5, 59, 110, 184). Thus, the
relevance of the Drosophila Tolls to immunity (besides the canonical protein Toll) has
remained largely mysterious. The importance of the Toll receptors in viral infection
outside of the canonical Toll signaling pathway, however, has not been thoroughly
assessed.
Whereas the Toll pathway primarily limits Gram-positive bacteria, a second
Drosophila NFκB pathway known as the immune deficiency (IMD) pathway preferentially
controls Gram-negative bacterial infection (121). The upstream receptors of the IMD
pathway are also members of the PGRP family, but in contrast to the Toll pathway PRRs
that recognize Lys-type PGN, the IMD pathway-associated receptors generally
recognize meso-diaminopimelic (DAP)-type PGN. PGRP-LC is a transmembrane sensor
that recognizes monomeric and polymeric DAP-type PGN at the cell surface, while
PGRP-LE exists in two forms that have both cell-autonomous and non-cell-autonomous
functions (115). On one hand, PGRP-LE is constitutively secreted into the open
circulatory system and activates the IMD pathway systemically in response to bacterial
infection (204). In addition to this extracellular role, PGRP-LE is also expressed within
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immune cells as an intracellular receptor for the PAMP tracheal cytotoxin (TCT), a
monomeric DAP-type PGN. IMD signaling proceeds through the death-domain (DD)containing adaptor IMD, which acts as a signaling platform that coordinates two distinct
mechanisms to activate the NFκB-like transcription factor Relish. First, Relish is
phosphorylated by the IKK signaling complex consisting of immune-response deficient 5
(IRD5) and the regulatory subunit Kenny (179, 194). This phosphorylation event is
thought to mark Relish for cleavage, which is dependent on a second complex recruited
to IMD composed of FAS-associated death domain (FADD) and the caspase-8 homolog
death-related ced-3/Nedd2-like protein (DREDD) (125, 150). The N-terminal domain of
Relish can then migrate to the nucleus to induce expression of AMP genes such as
Diptericin and Listericin (69, 100).
Along with this known antibacterial role, the IMD pathway also suppresses the
replication of certain arboviruses. Using an in vivo SINV replicon system, one study
showed that SINV replication triggers the expression of IMD-dependent AMP genes (7).
Activation of the IMD pathway is critical for antiviral defense, as mutants for several key
components of the IMD pathway (but not the Toll pathway) showed elevated viral loads
(7), and RNAi-mediated silencing of the IMD-dependent AMP Diptericin B also increased
viral titers (82). Additionally, IMD pathway mutants exhibited impaired resistance to
Cricket Paralysis virus (CrPV) infection, although CrPV did not induce AMP expression
by microarray analysis (46).
Besides canonical NFκB signaling, other evolutionarily conserved pathways also
have important functions in Drosophila antiviral immunity. For example, the Jak-STAT
pathway, which controls antiviral responses against certain viruses in mammals (58,
102), also coordinates an antiviral transcription program in flies during DCV infection
(55). Flies deficient in the Jak kinase Hopscotch showed impaired upregulation of DCV-
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induced genes including vir-1, as well as increased viral replication and mortality,
suggesting that the Jak-STAT pathway is required for resistance during DCV infection.
Another study demonstrated that the DEAD-box helicase Dicer-2, in addition to its
canonical role in antiviral RNAi, also mediates a transcriptional response during DCV
infection, including the expression of the antiviral gene Vago (48). This antiviral response
appears to be shared by other invertebrates, as West Nile virus triggered the secretion
of Vago in Culex mosquito cells, which restricted viral replication by activating Jak-STAT
signaling (165). Finally, recent studies showed that the nutrient-responsive ERK pathway
restricts a broad range of viruses in the Drosophila gut (233). Collectively, these findings
reveal that multiple conserved immune signaling pathways collaborate in directing
Drosophila antiviral immunity, with specific requirements for distinct pathogens.

4. Autophagy as a Conserved Innate Immune Response
Innate immune signaling is crucial for coordinating varied effector responses that
limit pathogen replication in host cells. Among known antimicrobial effector responses,
autophagy may be one of the most ancient. Autophagy is a deeply conserved biological
process by which cells break down cytoplasmic material through the lysosomal
degradation pathway (133). Found in eukaryotic organisms ranging from yeast to flies to
humans, autophagy is thought to have evolved as an adaptive response to cellular
stress including nutrient deprivation, as autophagic recycling of macromolecules is
critical for energy homeostasis and survival during periods of starvation (133, 145). This
bulk form of autophagy is generally considered to be a nonselective degradation
program capturing cytoplasmic material and organelles at random. It has become quite
clear, however, that autophagy can also selectively target particular cargo, including the
recycling of damaged organelles such as mitochondria and the targeted clearance of

10

protein aggregates too large for proteasomal capture (111, 243). As such, the functions
of autophagy have diversified in higher organisms to respond to cellular stresses beyond
starvation.
Indeed, mounting evidence demonstrates important roles for autophagy in
numerous pathological processes including cancer, aging, neurodegeneration and
inflammation (145). For example, autophagy genes have been shown to be required for
lifespan extension in response to treatments such as caloric restriction (74). Autophagic
vacuoles accumulate in brains of humans with neurodegenerative diseases, presumably
to help degrade pathogenic protein aggregates that underlie disorders such as
Parkinson’s disease and Alzheimer’s disease (156). In addition, loss of autophagy in
hepatocytes results in spontaneous development of benign tumors, indicating a tumorsuppressive function for autophagy in the liver (202). However, cancer cells also rely
heavily on autophagy to support heightened metabolic demands of proliferation (145).
Thus, autophagy may play both pathogenic and protective roles.
Because autophagy is the only known mechanism to remove cytoplasmic
contents that are larger than can be captured by the proteasome, it has also been
proposed as a likely component of the cell’s arsenal against infectious organisms.
Indeed, recent studies have demonstrated that autophagy captures and degrades
multiple classes of pathogens, including bacteria, viruses and parasites (52). This is not
absolute, as some pathogens have evolved means to either inhibit or evade autophagy
(108). Perhaps surprisingly, some pathogens have even co-opted the autophagic
machinery to enhance their replication (52). These complex interactions between
invasive organisms and autophagy suggest that antimicrobial autophagy has exerted
strong evolutionary pressures on pathogens. Yet, much remains to be discovered
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regarding the functional importance of antimicrobial autophagy and the mechanisms
regulating it.

5. Molecular Mechanism of Autophagy in Flies and Mammals
The cell biological process of autophagy and the factors that regulate this
pathway are deeply conserved. Autophagy proceeds through a series of defined stages
that ultimately result in the sequestration and degradation of cytoplasmic components
(145). Upon autophagy activation, an isolation membrane (also known as a phagophore)
begins to form in the cytoplasm. The nascent isolation membrane then elongates and
closes to generate the characteristic double-membraned structure known as the
autophagosome. These vesicles subsequently fuse with lysosomes, forming
autolysosomes that undergo acidification to activate lysosomal enzymes that degrade
the engulfed contents. Autophagosomes can also fuse with endosomes to form
structures known as amphisomes, although the function of this compartment in the
autophagy pathway has not been fully resolved (14).
Using largely genetic screening, previous studies in yeast have defined over 30
autophagy-related (Atg) genes that comprise the core molecular autophagic machinery
(247). The majority of these genes are conserved in flies and mammals both
phylogenetically and functionally, although some differences exist (Figure 1). For
example, a complex containing the serine/threonine kinase Atg1 initiates autophagy
across hosts (99). Whereas flies and yeast encode only one copy of Atg1, humans have
two closely related homologs (Unc-51-like kinase-1 (ULK1) and ULK2) that are
functionally redundant in starvation-induced autophagy (118). In yeast, the Atg1 complex
with Atg13 forms upon autophagy activation, but in both Drosophila and mammals, Atg1
forms a stable complex with Atg13 regardless of nutrient status (34, 79). The
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mammalian Atg1 complex also contains Atg101 and FIP200, which are required for
autophagosome generation (75, 80). Drosophila has orthologs of these proteins
(CG7053 and CG1347, respectively), but their roles in autophagy have not been tested.
Activation of the Atg1 complex leads to enhanced kinase activity and phosphorylation of
Atg1 and Atg13 (35), although the complement of Atg1 kinase targets remains unknown.
In yeast, Atg1 kinase activity is dispensable for the recruitment of downstream
autophagy proteins to the pre-autophagosomal structure (the site of autophagosome
formation) (37), but this may not be true in mammals, as expression of kinase-dead
ULK1 or ULK2 inhibits autophagy (32).
The next step of autophagosome biogenesis involves nucleation of the
autophagosomal membrane. In yeast, this process depends on a complex containing
Atg6 (Drosophila Atg6 and human Beclin-1), Atg14 (Drosophila CG11877 and human
Atg14), Vps15 (Drosophila ird1 and human PIK3R4) and the class III
phosphatidylinositol 3-kinase (PI3K) Vps34 (Drosophila Pi3K59F and human PIK3C3)
(247). Mammalian Vps34 complexes contain additional proteins including UVRAG,
Rubicon and Ambra1, two of which (UVRAG and Rubicon) are found in flies (196).
Activation of Vps34 leads to the production of phosphatidylinositol-3-phosphate, which is
enriched at the nascent autophagosome and signals the recruitment of additional
proteins including Atg18 (human WIPI1 and WIPI2) (231).
Elongation of the autophagosomal membrane is dependent on two conserved
ubiquitin-like protein conjugation systems. The first involves the covalent attachment of
Atg5 to Atg12 through the E1 and E2-like enzymes Atg7 and Atg10, respectively (145).
This Atg5-Atg12 complex is then noncovalently linked to Atg16 (humans have two Atg16
orthologs, Atg16L1 and Atg16L2) (146). While these genes are conserved in flies and
mammals, Atg10 and Atg16 have not yet been shown to function in autophagy in
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Drosophila. The second system involves conjugation of the lipid moiety
phosphatidylethanolamine to the ubiquitin-like protein Atg8 through the actions of Atg3,
Atg4 and Atg7, all of which have been functionally validated in Drosophila autophagy
(88). This modified form of Atg8 decorates the autophagosomal membrane and is
monitored by several autophagy assays to quantify autophagosome formation. Multiple
orthologs of Atg8 are found in flies (Atg8a and Atg8b) and mammals (LC3A, LC3B,
LC3C, GABARAP, GABARAP-L1, GATE-16, GABARAPL3), the significance of which is
largely unknown, although functional redundancies likely exist. Taken together, despite
some differences between the Drosophila and mammalian pathways, the molecular
players that mediate autophagy are conserved between flies and humans, and therefore
findings in Drosophila antimicrobial autophagy likely have broad relevance.
In both mammals and flies, autophagy is best studied for its role in nutrient
homeostasis. The nutrient signaling pathway senses extracellular growth factors, insulin
and amino acids, and under nutrient sufficient conditions, Class I PI3K signaling
activates the protein kinase Target of Rapamycin (TOR) which inhibits autophagy at the
level of the Atg1 complex (133). However, in response to starvation, TOR is inactivated
and this repression of autophagy is relieved (145). The nutrient responsive signaling
cascade is highly conserved from yeast to flies to humans: nutrient deprivation,
rapamycin treatment or genetic manipulation of TOR or related signaling components
(such as PI3K and the small GTPase Rheb) induces autophagy in all three systems
(183). Thus, not only is the core autophagic machinery conserved, but also the upstream
regulatory pathways.
Autophagy is also regulated at the level of gene transcription (76). A member of
the Forkhead box O (FoxO) family of transcription factors, FoxO3, binds to the
promoters of several autophagy genes such as LC3B in mammalian cells and activates
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gene transcription during autophagy (136). Similarly, FoxO deficiency impairs autophagy
activation in the Drosophila larval fat body, whereas overexpression of an active form of
FoxO is sufficient to promote autophagy (98). These data suggest that transcriptional
regulation of autophagy by FoxO genes is conserved between mammals and flies.
Several other conserved transcription factors including hypoxia-inducible factor-1 (HIF1), p53, E2F1 and NFκB have also been implicated in upregulating autophagy genes in
response to various stimuli in mammals (12, 45, 47, 168). More recently, transcription
factor EB (TFEB) has been described as a master positive regulator of autophagy that
drives expression of both autophagy and lysosomal genes (185). A homolog of TFEB
(Mitf) exists in flies, suggesting that a similar transcriptional network may control
autophagy and lysosomal biogenesis in flies.

6. Role of Autophagy in Bacterial Infection
Autophagy plays a critical role in restricting several types of bacteria that gain
access to and replicate within the cytosol. Indeed, autophagy proteins are recruited to
cytoplasmic bacteria upon infection, and ultra-structural studies have provided evidence
of bacteria sequestered within double-membraned autophagosomes (52). The
autophagic capture of intracellular bacteria is thought to restrict replication by targeting
the bacteria to the lysosome for degradation (52). One important pathogen controlled by
autophagy is Mycobacterium tuberculosis, the causative agent of tuberculosis. Early
studies showed that the activation of autophagy, such as by rapamycin treatment or
starvation, can inhibit the survival of M. tuberculosis and promote the recruitment of
autophagy markers like LC3 to mycobacteria-containing phagosomes (72). Autophagy
also functions as an antibacterial defense mechanism against M. tuberculosis in vivo, as
macrophage-specific loss of the autophagy gene Atg5 in mice increases susceptibility to

15

infection (28, 221). As well as impairing elimination of bacteria, autophagy deficiency
may promote increased bacterial uptake due to elevated expression of scavenger
receptors (20). Significantly, the importance of autophagy in bacterial clearance may
also extend to humans based on recent data showing that the autophagy-related
GTPase IRGM, which controls M. tuberculosis infection in vitro (197), is a genetic risk
locus for human infection (92).
In addition to M. tuberculosis, several other intracellular bacteria engage the
antibacterial autophagy pathway in mammalian cells, including Staphylococcus aureus,
Listeria monocytogenes, Salmonella enterica serovar Typhimurium and Shigella flexneri
(18, 151, 159, 170). Interestingly, however, bacterial pathogens have evolved diverse
mechanisms to antagonize autophagy. For instance, autophagy can also degrade
intracellular L. monocytogenes in mammalian cells, but this process is normally
impeded, as L. monocytogenes possesses several mechanisms to actively evade
autophagic recognition. The bacterial protein ActA, which is injected into the cytoplasm,
inhibits the cellular ubiquitylation machinery from marking the pathogen for
autophagosomal degradation (242). A second L. monocytogenes-encoded protein, InlK,
has also been implicated in autophagy evasion independently of ActA, although the
mechanism is unclear (54). Like L. monocytogenes, Shigella also avoids autophagic
capture by camouflaging one of its own molecules VirG, which promotes actin-based
motility. The binding of VirG to host Atg5 can promote autophagy, but in wild-type
Shigella, IscB is secreted into the cytoplasm via the type III secretion system and
competitively inhibits this interaction (159). These multiple evasion mechanisms
emphasize the importance of autophagy in innate immunity against intracellular bacterial
infection, which has necessitated continuing adaptation by bacteria to counteract this
response.
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Supporting the important role that autophagy plays in human and mouse models
of bacterial infection, additional data suggest that antibacterial autophagy is an
evolutionarily conserved innate immune response in the fly. While IMD and Toll signaling
pathways are dispensable for containing intracellular L. monocytogenes in flies,
autophagy restricts L. monocytogenes replication once the bacterium has escaped into
the cytoplasm (238). L. monocytogenes invades and replicates in the macrophage-like
blood cells of Drosophila, termed hemocytes. Yano et al. found that in both primary
hemocytes and a hemocyte-derived Drosophila cell line, L. monocytogenes infection
induced autophagy, as shown by the appearance of GFP-tagged LC3 puncta (commonly
used to monitor autophagosome formation) that co-localized with internalized bacteria.
Importantly, autophagy restricted L. monocytogenes growth, as RNAi-mediated silencing
of core autophagy genes in both cells and whole organisms resulted in increased
bacterial replication, as well as decreased survival in adult flies post-infection.
Collectively, these experiments were the first to unveil an essential antibacterial
autophagy program in Drosophila.
While antibacterial autophagy in Drosophila is most precisely defined in L.
monocytogenes infection, recent studies suggest that other bacteria may also be
controlled by autophagy. For example, multiple hosts utilize autophagy to restrict
replication of Wolbachia, a common endosymbiotic bacterium found in arthropods and
filarial nematodes (218). Activation of autophagy (such as with starvation or rapamycin
treatment) reduced bacterial loads in Aedes aegyptii mosquito cells or adult flies (218).
In contrast, inhibiting autophagy via siRNA depletion of Atg1 in flies enhanced bacterial
replication. Another study showed that the antibiotics rifampicin (an inhibitor of the
bacterial RNA polymerase) and amikacin (an aminoglycoside that inhibits bacterial
protein synthesis through irreversible binding to the 30S ribosome) activate autophagy
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during Mycobacterium marinum infection, and that autophagy genes are necessary for
these antibiotics to reduce bacterial growth (106). Finally, mutants in ird1, a component
of the PI3K autophagy complex, display dysregulated AMP expression and enhanced
susceptibility to bacterial infection by the Gram-positive bacterium Micrococcus luteus
and the Gram-negative bacterium Escherichia coli (228). It remains to be determined
whether the requirement for ird1 is due to a direct role of autophagy in clearing the
bacteria.

7. Restriction of Viral Infection by Autophagy
As obligate intracellular parasites, viruses co-opt cellular machinery and replicate
within the host cell. Therefore, to combat viral infection, cells rely on multiple intrinsic
mechanisms that promote virus elimination or protect against the pathogenic effects of
virus growth. Similar to intracellular bacteria, several viruses can activate autophagy or
recruit autophagy proteins to sites of replication, and in some cases, autophagy has
been shown to be a potent inhibitor of viral infection (240).
A number of studies have demonstrated that autophagy impacts viral replication
and pathogenesis in certain mammalian viral infections. Neuronal overexpression of the
autophagy protein Beclin 1 (the mammalian homolog of Atg6) in neonatal mice protects
against SINV pathogenesis (127). Moreover, mice lacking Atg5 expression in neurons
succumb more readily to SINV infection due to impaired viral capsid clearance, although
autophagy does not seem to restrict viral replication per se (162). Interestingly, like
several bacteria that evade autophagic capture, many viruses also encode autophagy
antagonists that are required for pathogenesis. Herpes simplex virus type 1 (HSV-1) can
block autophagy via the viral protein ICP34.5, which utilizes two independent
mechanisms: binding and inhibiting Beclin 1 (161), and antagonizing PKR-dependent
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autophagy induction (206). Mice infected with ICP34.5-mutant viruses more easily clear
the virus and exhibit decreased lethal encephalitis compared to mice infected with wild
type viruses, demonstrating an important function for antiviral autophagy in vivo (161).
HSV-1 also encodes a second autophagy antagonist Us11, which directly interacts with
PKR to inhibit autophagy (135). Autophagy seems to have a particularly protective role
against HSV-1 infection in specific types of cells like dorsal root ganglionic neurons,
which are less sensitive to Type I interferon than mitotic cells such as epithelial cells
(239). More recent data suggest that autophagy can also control other viruses, including
human immunodeficiency virus (HIV), encephalomyocarditis virus and human papilloma
virus in mammalian cells in certain contexts (26, 31, 51, 200). Thus, multiple viruses can
trigger autophagy in mammalian systems, but the in vivo significance of this activation
remains largely unclear, and the molecular mechanisms that regulate this process are
poorly understood. The role of antiviral autophagy in mammalian infection is also
complicated by the fact that autophagy simultaneously regulates other immune
pathways such as Type I interferon signaling and inflammasome activity (117, 205).
Since Drosophila are infected by viruses and are a genetically tractable model,
flies are well suited for probing the interactions between viruses and autophagy. Indeed,
recent data demonstrate that autophagy is a conserved and essential component of the
innate antiviral arsenal against the negative-sense Rhabdovirus VSV in flies. VSV
induced autophagy in cells (including primary hemocytes), and Drosophila S2 cells
depleted of several genes in the core autophagic machinery exhibited increased viral
infection (188). Moreover, VSV infection also triggered autophagy in adult flies, and
RNAi-mediated silencing of autophagy genes elevated viral replication and mortality
after infection, revealing a fundamental antiviral role for autophagy in vivo. Antiviral
autophagy during VSV infection seems to be regulated at least in part by the canonical
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nutrient signaling PI3K-Akt pathway. VSV infection decreased activation of this pathway
as shown by diminished Akt phosphorylation (which is known to promote autophagy),
while genetic modulation of PI3K-Akt signaling impacted viral replication. Collectively,
these data provide additional evidence that autophagy is an ancient antiviral defense
response, and importantly, plays a critical role in host immunity at the organismal level.

8. Regulation of Autophagy by PRRs
Because of the fundamental role of autophagy in resistance to diverse microbes,
it is essential to understand the mechanisms by which autophagy is initiated during
infection. Several lines of evidence indicate that signaling through various PRRs can
regulate autophagy, which has further expanded the repertoire of PRRs beyond their
classical functions. As such, the PRR-autophagy axis may have a direct effect on
controlling bacterial and viral infection.
TLRs were the first category of PRRs implicated in eliciting autophagy. The
canonical TLR4 ligand LPS induced autophagy in both murine and human
macrophages, and this response promoted colocalization of autophagosome markers
with intracellular bacteria (235). Furthermore, autophagy activation can be observed
using canonical ligands for TLR1, TLR3, TLR5, TLR6 and TLR7 in macrophages (50,
190), and a recent study found that TLR8 ligands can activate vitamin-D-dependent
autophagy in human macrophages to restrict HIV replication (25). The exact signaling
mechanism that leads to autophagy downstream of TLR ligation remains somewhat
unclear, as different studies have produced contrasting results. For example, in one
study, LPS-induced autophagy did not require the canonical TIR adapters, MyD88 and
TRIF, and instead depended on receptor-interacting protein 1 (RIP1) and the p38
mitogen-activated protein kinase (235). However, others studies found a requirement for
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either MyD88 or TRIF in TLR-triggered autophagy (49, 190). Tumor necrosis factor
receptor-associated factor-6 (TRAF6) has also been shown to regulate TLR4-induced
autophagy by phosphorylating Beclin 1, although TRAF6 may have indirect effects on
autophagy as well (191). The exact role of TLR-dependent autophagy during infection
remains undetermined as most studies have utilized synthetic ligands, but more recent
studies have begun to address some aspects of this question. For example, one study
showed that L. monocytogenes infection in macrophages requires TLR2 and RIP2 to
activate autophagy through the control of ERK signaling (4). Another study has
demonstrated that invasive S. typhimurium activate autophagy in intestinal epithelial
cells via MyD88, although whether a specific TLR is required to recognize the bacteria is
unknown (13). Thus, TLR-mediated autophagy may be an important innate response,
but evidence for its role in vivo and during viral infection is lacking.
Other PRRs besides TLRs have also been linked to autophagy activation in
mammalian cells. Nod1 and Nod2 are NLRs that reside in the cytoplasm and recognize
degradation products of PGN, similar to PGRP-LE: Nod1 acts as a sensor for molecules
containing meso-diaminopimelic acid (meso-DAP), whereas Nod2 is stimulated by
muramyl dipeptide (MDP) (101). In mice, Nod1 and Nod2 interact with the autophagy
protein Atg16L1, and this interaction localizes Atg16L1 to the plasma membrane at the
site of bacterial entry (212). Intriguingly, in humans, polymorphisms in NOD2 and
ATG16L1 have been linked to Crohn’s disease (85, 172), suggesting that perhaps NLRcontrolled autophagy may affect human inflammatory disorders.
The function of mammalian NLRs in autophagy closely parallels the role of
Drosophila PRRs in antibacterial autophagy, indicating a conserved link between PRRcontrolled autophagy across species. Experiments in flies showed that a PRR previously
implicated in the IMD pathway detects L. monocytogenes components to trigger
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autophagy (238). PGRP-LC and PGRP-LE have non-redundant functions: while PGRPLC controls extracellular bacteria in the hemolymph, PGRP-LE restricts bacterial
replication within cells. This divergence is due to the requirement of PGRP-LE but not
PGRP-LC in antibacterial autophagy. PGRP-LE was necessary for autophagy induction
in response to L. monocytogenes (Figure 2A), as well as the PAMPs TCT and DAP-type
PGN (but not Lys-type PGN, which signals through an unknown cytoplasmic PRR)
(238). Thus, bacterial detection by a cytosolic PGN-sensing pathway is a critical
component of antibacterial autophagy in flies. Unexpectedly, though PGRP-LE can
signal through the IMD pathway, components of the IMD pathway were not required for
either autophagy or intracellular bacterial restriction, suggesting that an unknown
signaling pathway links PRR engagement to antibacterial autophagy in flies.
Nevertheless, these data indicate that recognition of PGN derivatives by cytosolic
sensors is a shared pathway regulating autophagy induction between flies and
mammals, although whether the mechanism downstream of PRR engagement is
conserved must be further resolved.
While the role of PRR-triggered autophagy in viral infection is poorly
characterized, some observations in flies may provide clues to PRRs required in antiviral
autophagy. Perhaps surprisingly, VSV replication intermediates and viral nucleic acids
were not required for the induction of antiviral autophagy in Drosophila cells, as UVinactivated VSV induced a response similar to replication-competent virus, and incoming
viral RNA or ribonucleoprotein complexes were inert (188). Rather, the viral glycoprotein
VSV-G was sufficient to induce autophagy, suggesting that VSV-G acts as a PAMP
upstream of antiviral autophagy (Figure 2B). However, the exact PRR that recognizes
VSV-G to elicit autophagy was not resolved.
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8. Aims of Present Studies
The innate immune system acts as the first line of defense during infection and
confers broad protection against diverse pathogens. Arising before the separation of
vertebrates and invertebrates, innate immunity is the most ancient defense system, with
many eukaryotic organisms including insects solely depending on it for antimicrobial
resistance. Impressively, invertebrate models such as Drosophila have provided critical
insights into our understanding of innate immune signaling and effector responses,
revealing considerable conservation between humans and lower organisms. In
particular, Drosophila is an adept model for understanding arboviruses, as parallels can
be drawn with both the insect vector and mammalian host. Arboviral infections represent
a growing human health concern, and notably, there are no effective antiviral
therapeutics for treating infection. As a result, novel insights into the innate immune
pathways that control arboviral infection in vector insects and mammals are desperately
needed. Therefore, the work described in Chapter III and Chapter IV aims to identify
molecular mechanisms regulating antiviral autophagy, a robust and ancient immune
response against viruses in the fly, and apply findings to medically relevant human
arboviruses in invertebrate and mammalian systems.
Previous work demonstrated that autophagy is an essential antiviral response
during VSV infection in flies, but it was unclear exactly how autophagy was activated by
viral infection (188). Curiously, the VSV glycoprotein VSV-G was sufficient to elicit
autophagy, indicating that flies may encode an unknown receptor that functions as a
PRR for VSV. In Chapter III, I describe a targeted RNAi screen of candidate VSV PRRs,
the Drosophila Toll receptors, which identified the previously uncharacterized receptor
Toll-7 as a novel VSV restriction factor in vitro. Toll-7 is also necessary for resistance to
VSV infection in adult flies and functions as a bona fide PRR, as it is the first Drosophila
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Toll receptor shown to physically interact with a pathogen. Moreover, Toll-7 is necessary
to activate VSV-induced autophagy in Drosophila cells and adult flies, demonstrating
that Toll-7 is the missing link between virus recognition and antiviral autophagy
activation. Importantly, these studies define the significance of the PRR-autophagy axis
during infection in vivo.
While VSV is not generally pathogenic in humans, other arboviruses can cause
severe clinical manifestations. Therefore, to further define the breadth of arboviruses
restricted by this PRR-autophagy axis, I performed an in vivo screen of Drosophila Toll
receptor mutants and discovered a novel role for Toll-7 in activating antiviral autophagy
against RVFV infection in vivo, which is described in Chapter IV. Because autophagy is
highly conserved across organisms, I next tested the role of autophagy genes in RVFV
infection of mouse and human cells. I found that autophagy is similarly required to
restrict RVFV infection in mammals and is activated by known TLR and nutrient
signaling pathways as in flies. Lastly, autophagy activation potently inhibited viral
replication in cell lines and primary cells such as neurons, demonstrating the autophagy
pathway may be a viable target for developing novel therapeutics to control RVFV
infection across insect and mammalian hosts.
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Figure 1. Comparison of autophagy pathways in Drosophila and mammals.
In both flies and mammals, autophagy proceeds through three defined stages that
depend on a number of conserved genes comprising the core autophagic machinery.
Autophagy is regulated by the nutrient signaling pathway, in which the kinase TOR
normally inhibits autophagy under nutrient-rich conditions. Autophagy initiation involves
a multi-protein complex containing Atg13 and the serine/threonine kinase Atg1, which
activates formation of the pre-autophagosomal membrane. Nucleation of the preautophagosomal membrane is mediated by a complex that contains the Type III PI3K
Vps34. Elongation of the membrane proceeds through two ubiquitin-like conjugation
steps. Atg8 (LC3) acquires a phosphatidylethanolamine group to form Atg8-II (LC3-II),
which is incorporated into the nascent autophagosomal membrane and helps recruit
substrates for degradation. In the second reaction, Atg5 is conjugated to Atg12, which
then associates with Atg16. Genes that have not been validated in autophagy in
Drosophila are depicted as white boxes.
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Figure 2. Drosophila antimicrobial autophagy in bacterial and viral infection.
A. Listeria monocytogenes is a Gram-positive bacterium that invades the cytoplasm.
Intracellular bacteria are detected by the PRR PGRP-LE, which senses peptidoglycan
(PGN) derivatives that are components of the bacterial cell wall. PGRP-LE recognition
activates several signaling pathways, including the activation of antimicrobial peptide
production by the IMD and Jak-Stat signaling pathways, as well as autophagy. L.
monocytogenes is found within autophagosomes, which mature and degrade the
captured bacteria. It remains to be determined the exact signaling pathway involved in
triggering autophagy during L. monocytogenes infection, as canonical pathways such as
the IMD and Toll pathways are not required. B. VSV activates autophagy in flies likely
through the viral glycoprotein VSV-G, which acts a PAMP and is recognized by an
unknown receptor. Previous research suggests that the nutrient signaling PI3K-Akt-TOR
pathway, which typically constrains autophagy, is downregulated during VSV infection to
trigger autophagy activation. It is still not understood exactly how autophagy restricts
VSV replication, i.e. whether intact virions or viral proteins are captured by
autophagosomes.
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II. MATERIALS AND METHODS

1. Cells and Cell Culture
Drosophila S2 and DL1 cells were maintained at 25°C in complete Drosophila media
(Schneider’s Drosophila medium (Gibco) containing 10% FBS, GlutaMAX (Gibco) and
penicillin/streptomycin (Gibco)). MEFs, U2OS and BHK-21 cells were maintained at
37°C in DMEM supplemented with 10% FBS (Sigma), 100 µg/mL penicillin/streptomycin
and 2mM L-glutamine. TBK1-/- MEFs were from K. Fitzgerald; MAVS-/- MEFs were from
J. Kagan; MyD88-/- MEFs were from R. Medzhitov; mCherry-GFP-LC3 U2OS cells were
from C. Coyne. Primary rat neuroglial cells were isolated from embryonic day 17
Sprague Dawley rat pups as previously described (199) and plated on plates pre-coated
with poly-L-lysine (Sigma). Neuronal cells were cultured in neurobasal media
supplemented with B27 (Invitrogen). For primary hepatocyte isolation, livers of C57Bl/6
mice were perfused with 1X HBBS solution followed by1X HBSS containing 0.1 M CaCl2
and 5mg/ml Liberase (Fisher Scientific). The digested liver and cells were further
agitated by pipetting and treated with ACK lysis buffer (Lonza) and collected through a
70-µm cell strainer. Digested cells were centrifuged at slow speed (50 g) for 5 minutes
and the pellet (hepatocytes) was resuspended in collection media (DMEM + 10% FBS).

2. Viruses
MP12 strain of RVFV was grown in BHK-21 cells supplemented with 10% FBS (63).
VSV-GFP was grown in BHK cells as described (171). SINV-GFP (gift from R. Hardy)
was grown in C636 cells as described (23). FHV (gift from P. Ahlquist) was grown in DL1
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cells. DCV was grown and purified as described (39). RVFV was inactivated with UV
light using a UV Stratalinker 2400 (Stratagene) and tested for infectivity.

3. Antibodies and Reagents
Antibodies were obtained from the following sources: anti-GFP (Invitrogen), antitubulin (Sigma), anti-actin (Sigma), anti-VSV-G (Santa Cruz), anti-LC3B (Sigma), antip62 (Sigma), anti-Atg5 (Sigma), anti-Atg7 (Sigma), anti-Beclin 1 (Cell Signaling), antiMyD88 (Abcam), anti-TRIF (Cell Signaling), anti-TRAF6 (Santa Cruz), anti-phosphodAkt Ser505 (Cell Signaling), anti-phospho-Akt Ser473 (Cell Signaling, anti-Akt (Cell
Signaling), anti-RVFV N ID8 (gift from R. Doms), anti-RVFV Gn 4D4 (gift from R. Doms),
anti-Atg8 (188) and anti-DCV (39). The Toll-7 antibody was raised in rabbits against
peptide (CELRRSVHDALRGRPQK) and affinity purified (ProSci). Fluorescently labeled
antibodies were from Invitrogen, and HRP antibodies from Amersham. Drugs were
obtained from the following sources: rapamycin (Sigma), SMER28 (EMD Millipore) and
chloroquine (Sigma).

4. dsRNA Synthesis
dsRNAs for RNAi were designed using the SnapDragon design tool
(flyRNAi.org). For each amplicon, a region of ~250-500 bp within an exon of the target
gene was selected. Forward and reverse primers containing the T7 RNA polymerase
promoter sequence TAATACGACTCACTATAGG were designed to amplify the region of
interest, and two rounds of PCR were performed using Drosophila genomic DNA as the
template. PCR products were then used as templates for in vitro transcription using the
MEGAScript T7 kit (Ambion) and dsRNA was purified using an RNeasy kit (Qiagen)
following the manufacturer’s instructions.
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5. RNAi in Drosophila cells
Drosophila cells in serum-free media were plated at a density of 17,000 cells/well
for 384-well plates and 2.5x106 cells/well for 6-well plates with 250 ng dsRNA or 4 µg
dsRNA, respectively. Forty-five minutes later, complete media was added and cells were
incubated at 25°C for three days to allow for efficient knockdown.

6. siRNA Transfection
U2OS cells were plated at a density of 300,000 cells/well in 6-well plates or 1.5e6
cells/well in 10-cm dishes and transfected with siRNAs at a final concentration of 10 nM
using HiPerFect transfection reagent (Qiagen). The siRNAs were obtained from the
following sources: non-targeting control, Atg5, Atg7, Fip200, Atg13 (Ambion); MyD88,
TRIF (Dharmacon); Beclin 1 (Cell Signaling); TRAF6 (Qiagen). Cells were processed for
immunoblot or infected on day three post-transfection.

7. Viral Infections for Cell Culture Experiments
Drosophila cells were infected three days after dsRNA bathing with the indicated
VSV inoculum for 24 hours. Mammalian cells were infected with VSV, SINV or RVFV at
the indicated MOI for 12-18 hours as indicated. For 96-well experiments with RVFV
infection, cells were spin-infected in serum-free media for one hour, after which complete
media was added. For autophagy activator experiments, drugs were added to the wells
at the final concentration indicated one hour prior to infection.

8. Adult Fly Maintenance and Infections
Flies were maintained on standard medium at room temperature. The following flies
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carrying snap-back transgenes were obtained from the VDRC: UAS-CG5490 IR (Toll),
UAS-CG8896 IR (Toll-2), UAS-CG1149 IR (Toll-3), UAS-CG18241 IR (Toll-4), UASCG7121 (Toll-5), UAS-CG7250 IR (Toll-6), UAS-CG8595 IR (Toll-7), UAS-CG6890 IR
(Toll-8) and UAS-CG5528 IR (Toll-9). A second snap-back transgene against Toll-7 was
obtained from Bloomington (TRiP.HM05230). Flies bearing snap-back transgenes were
crossed to Actin-GAL4/+ flies at room temperature or heat shock-GAL4 as indicated. Toll
mutants were generated by crossing Tlr444/TM3 Sb to Tl9QRE/TM3 Ser. Toll-2 mutants
were generated by crossing 18wΔ7-35/Cyo to Df(2R)017/SM1 (128). Toll-7g1-5/CyO were
crossed to Df(2R)BSC22/CyO to generate Toll-7 mutants (236). Toll-859 was crossed to
Df(3L)Brd15 to generate Toll-8 mutants. Homozygous Toll-6 mutants (Toll-6ex70) and
Toll-9 mutants (Toll-9rv17) were compared to heterozygous sibling controls (236). Toll
pathway mutants MyD88EP2133 (208) and Dif 1/2 were challenged with VSV (178).
Homozygous Traf6 mutant flies (Traf6Ex1) were compared to heterozygous sibling control
flies (30). Toll receptor overexpressing flies were generated by crossing heat-shock Gal4
to UAS-Toll-3, UAS-Toll-4, UAS-Toll-5, UAS-Toll-6, UAS-Toll-7, UAS-Toll-8 and UASToll-9 (236). UAS-Atg18 IR (VDRC), UAS-Atg5 IR, UAS-Atg7 IR and UAS-GFP-Atg8a
were crossed to Actin-Gal4 or YP1-Gal4 (81).
Four- to seven-day-old flies of the indicated genotypes were inoculated with
vehicle or virus as previously described (188). Heat shock flies were shocked for 1 hour
at 37°C on the day of injection and every 2 days throughout the experiment. Flies were
monitored for mortality or processed at the indicated time points post-infection. For
autophagy studies, flies were dissected in complete Schneider’s media with Lysotracker
red (Invitrogen), incubated for 10 min, rinsed in media and mounted live for imaging
(Leica) (188). For rapamycin feeding experiments, flies were starved for one hour,
placed on food supplemented with 100 µM rapamycin or vehicle and infected the next
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day. To monitor Akt activity, flies were challenged with insulin (1 mM) and either PBS or
RVFV as previously described (188).

9. Immunofluorescence
Cells were fixed in 4% formaldehyde/PBS, washed twice in PBS/0.1% Triton X-100
(PBST) and blocked in 2% BSA/PBST. Primary antibody was diluted in block and
incubated overnight at 4°C. Cells were washed in PBST, incubated with secondary
antibody for one hour at room temperature and counterstained with Hoechst33342
(Sigma). Automated microscopy (ImageXpress Micro) was used to image cells on 96well and 384-well plates with at least four sites per well and three sites per condition,
and percent infection was quantified using MetaXpress image analysis software. IC50
values were quantified using GraphPad Prism. Neurons plated on coverslips were
imaged using a Leica DMI 4000 B fluorescent microscope.

10. LC3 puncta analysis
S2* cells were transfected with pMT-Gal4 and UAS-GFP-LC3 and infected with VSV as
previously described (188). Greater than 150 cells per treatment were counted for three
independent experiments. U2OS cells stably expressing mCherry-GFP-LC3 were plated
at a density of 40,000 cells per coverslip. The next day, cells were treated with drugs at
the indicated concentration or infected with RVFV or UV-inactivated RVFV for the
indicated times. Fat bodies from YP1-GAL4> UAS-GFP-Atg8a flies were dissected at the
indicated time point post-infection. LC3 puncta were quantified using the MetaXpress
image analysis granularity application.

11. Immunoblotting and Immunoprecipitations
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Cells or flies were collected at the indicated time points and lysed in
radioimmunoprecipitation assay (RIPA) buffer supplemented with a protease inhibitor
cocktail (Boehringer) and blotted as previously described for immunoblots (188). Cells or
purified virus were biotinylated using Sulfo-NHS-LC-Biotin following the manufacturer’s
protocol (Thermo). For immunoprecipitations, 15x106 Drosophila DL1 cells samples were
plated on 10 cm dishes. One day after plating, cells were chilled for one hour at 16ºC,
incubated with biotinylated virus or IgG for one hour at 4ºC and lysed in lysis buffer
(20mM Tris at pH 7.6, 150 mM NaCl, 2mM EDTA, 10% glycerol, 1% Triton X-100, 1mM
DTT, and protease inhibitors) (1). Protein lysates were pre-cleared with protein A/G
agarose and precipitated overnight with streptavidin-agarose.

12. Plaque Assay
Viruses were titered on MEFs or BHK cells as indicated. Confluent monolayers
were incubated with serial dilutions of virus for 45 minutes, overlayed with agarose and
incubated for 24-72 hours at 37ºC. Cells were fixed in 4% formaldehyde/PBS, and
plaques were stained using crystal violet.

13. Northern Blotting
Total RNA was extracted from cells or flies using Trizol (Invitrogen). 10-20 µg
total RNA was separated on a 1% agarose/formaldehyde gel prepared in MOPS buffer
(2mM MOPS, 50mM NaOAc, 10mM EDTA, pH7.0). Gels were washed twice in water
and transferred to a Hybond N+ membrane (Amersham) overnight at room temperature.
Blots were UV-crosslinked using a Stratalinker 2400 (Stratagene) and pre-hybridized in
Church buffer (0.5M NaPO4, 7% SDS, 1mM EDTA) for 30 minutes. Membranes were
incubuated overnight at 65°C with PCR probes that had been internally radiolabeled
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using a Prime-It II Random Primer Labeling kit (Stratagene) in the presence of [α32

P]dCTP and purified over a MicroSpin G-50 column (Amersham). Blots were washed

twice using 2X SSC/0.1% SDS and once using 0.2X SSC / 0.2% SDS. Blots were
exposed to a phosphorimager cassette and imaged using a Typhoon imager (GE
Healthcare). Relative RNA levels were were normalized against controls (RpS6,
GAPDH) and quantified using ImageQuant software (Amersham).

14. Quantitative RT-PCR. Total RNA was isolated from cells using Trizol (Invitrogen)
and 1 µg RNA was reverse-transcribed with MMLV-RT using random priming according
to manufacturer’s instructions (Invitrogen). cDNA was subject to PCR and analyzed by
relative quantification by normalizing to GAPDH.

15. Oligonucleotide Sequences
Toll forward 5’-TGCGTGCAGTGAGATGAGCATAGA-3’,
Toll reverse 5’-TGATCTGCACGTAGTCTTTGGGCT-3’;
Toll-2 forward 5’-TAATACGACTCACTATAGGTGCTGACCTGCGACAGATAC-3’,
Toll-2 reverse 5’-TAATACGACTCACTATAGGTGTACTCCGACTCGATGCTG-3’;
Toll-3 forward 5’-ACACACACCGTGCTCATAGAACCA-3’;
Toll-3 reverse 5’-TTATTTGGCACTCGCGATCTCCCT-3’;
Toll-4 forward 5’TTGCTGCGTCGACACCTCAAATTC-3’,
Toll-4 reverse 5’-GCAAGCTGGATGGCCATTTCTTGA-3’;
Toll-5 forward 5’-ATCAGGCCACATTGCAGGACAAAC-3’,
Toll-5 reverse 5’-TGTTCAGCTTGAGATAGGCTCGCA-3’;
Toll-6 forward 5’-ACTGCAAGTTGCTGAACAACAGGG-3’,
Toll-6 reverse 5’-TCGAACTCACAGCAATGGCAAACG-3’;
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Toll-7 forward 5’-TGCACTGGAAGATAGCAGCTCGAA-3’,
Toll-7 reverse 5’-AGCAGCCAGCAAGGGAATATACGA-3’;
Toll-8 forward 5’-TCTTCTTTCGCTGAGGGTTGTGGA-3’,
Toll-8 reverse 5’-TGGGAATTCAGTTCGTTGCTTGCC-3’;
Toll-9 forward 5’-TTGCAAAGTCTTGGGTCGCTTTCG-3’,
Toll-9 reverse 5’-TCTTTGAGGTCAGCAAGGAGCACT-3’.

qRT-PCR primers are as follows:
mouse ISG56 forward 5’-CCAAGTGTTCCAATGCTCCT-3’;
mouse ISG56 reverse 5’-GGATGGAATTGCCTGCTAGA-3’;
mouse GAPDH forward 5’-ACCCTGTTGCTGTAGCCGTATTCA-3’;
mouse GAPDH reverse 5’-TCAACAGCAACTCCCACTCTTCCA-3’;
rat GAPDH forward 5’-GACATGCCGCCTGGAGAAAC-3’;
rat GAPDH reverse 5’-AGCCCAGGATCGCCTTTACGT-3’;
RVFV forward 5’-CAAGCAGTGGACCGCAATGAGA-3’;
RVFV reverse 5’-GGGCTTGTTGCCACGAGTTAGA-3’;
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III. VIRUS RECOGNITION BY TOLL-7 ACTIVATES ANTIVIRAL AUTOPHAGY IN
DROSOPHILA 1
1. Background
Detection and clearance of viruses by the innate immune system involves
several distinct and essential pathways that are evolutionarily conserved (94). These
pathways rely on pattern recognition receptors (PRRs) to recognize pathogenassociated molecular patterns (PAMPs), molecular signatures shared by wide classes of
invading organisms, and induce an appropriate effector response to clear the infection.
One important class of PRRs are the Toll-like receptors (TLRs), which were first
identified in Drosophila through their homology to Toll, and are now recognized as the
canonical pathogen recognition system in all metazoans (214).
Drosophila encodes nine Toll receptors (16). The first to be identified, Toll, is the
upstream receptor for the Toll pathway, which is the main defense against Gram-positive
bacterial and fungal infections and is conserved in many insects (29, 121, 122). These
microbes are sensed by a variety of recognition molecules that activate a proteolytic
cascade converging on the activation of spätzle, a cytokine that binds to Toll thereby
inducing an NF-kB-dependent transcriptional program for antimicrobial defense.
Surprisingly, a role for the additional eight Drosophila Toll homologues in innate immune
defense has yet to be established. Toll-2 (18-wheeler) may have a minor role in the
antibacterial response (128, 227), and Toll-5 (Tehao) and Toll-9 can activate the
expression of the antifungal gene Drosomycin (16, 134, 160, 207). However, these
receptors have not been implicated as essential components of the immune response or

1. This chapter is reprinted from Nakamoto, N., R. H. Moy, J. Xu, S. Bambina, A. Yasunaga, S. S.
Shelly, B. Gold, and S. Cherry. 2012. Virus recognition by Toll-7 activates antiviral autophagy in
Drosophila. Immunity 36: 658-667, with permission from Elsevier.
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in the recognition of any pathogen (153, 236).
In contrast to Drosophila, studies have quickly identified a role for the 10 human
TLRs in immunity. Mutants in the TLRs are more susceptible to infection, and the
PAMPs recognized by TLRs have been well-characterized. Viral nucleic acids are
recognized via endolysosomal TLRs (TLRs 3,7,8,9) while viral glycoproteins can be
recognized by TLRs present on the cell surface (e.g. TLR4) (3, 105). Unlike the indirect
recognition of microbes by Toll, the mammalian TLRs generally bind microbial PAMPs
directly to activate innate immune effectors (95).
One such effector pathway is autophagy, which can be induced by TLR
signaling, although its in vivo significance is unknown (49, 234). Autophagy is an ancient
and conserved pathway that degrades intracellular components and can restrict a
variety of intracellular pathogens, including viruses (52, 119, 126, 140). In Drosophila,
autophagy is triggered upon recognition of the VSV glycoprotein, VSV-G, and this
pathway is essential for antiviral defense in adult flies (188). The response can be
activated by viral recognition independently of viral replication, and thus we
hypothesized that VSV might be recognized by a Drosophila PRR controlling antiviral
autophagy. As the TLRs are known PRRs and VSV-G was previously shown to induce
TLR4 signaling in mammalian cells (67), we reasoned that one of the nine Drosophila
Tolls could be the PRR linking viral recognition to this innate immune response. By
screening mutants in the nine Drosophila Tolls both in cells and adult flies, we found that
VSV was recognized by Toll-7, which restricted viral replication and thereby protected
flies from an otherwise lethal infection. Toll-7 interacted with VSV virions at the plasma
membrane, and this recognition was required for the induction of antiviral autophagy.
Together, these data demonstrate that pathogen recognition by Drosophila Tolls may be
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more similar than previously assumed to the mammalian systems and that there may be
unknown roles for the additional Tolls in antiviral defense.

2. Results

Toll-7 restricts VSV infection in cultured cells
To determine whether any of the Drosophila Tolls are involved in antiviral
defense against VSV, we generated double-stranded RNA (dsRNA) against each of the
nine Toll receptors and depleted them in Drosophila S2 cells using RNA interference
(RNAi). Efficient silencing for each Toll receptor was confirmed by reverse transcriptasepolymerase chain reaction (RT-PCR) (Figure S1). Next, we challenged RNAi-treated
cells with VSV-GFP and subsequently analyzed the infection using fluorescence
microscopy and automated image analysis. We observed an increase in the percentage
of infected cells upon silencing of Toll-7 and Toll-2 but not other Tolls (Figure 3A,B). This
increase was similar to that observed upon silencing of Atg8, an essential autophagy
protein. Immunoblot analysis further confirmed that there was an elevation in the amount
of GFP production in cells depleted of Toll-7 or Toll-2 but not other Toll receptors (Figure
3C, not shown). Interestingly, Toll-7 and Toll-2 are highly similar, showing 61% identity
and 74% similarity, and are located in close chromosomal proximity (250kb apart).
Taken together, our data suggest that Toll-7 and Toll-2 might represent a gene
duplication and play a similar antiviral role in vivo (236).

Toll-7 is essential for antiviral defense in adult flies
As Drosophila Toll-7 and Toll-2 were antiviral in vitro, we next investigated
whether these receptors or any of the other Tolls play similar innate antiviral roles in the
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adult organism. Using in vivo RNAi, we screened these genes to determine whether loss
of any of these factors had an effect on VSV replication. Toll receptor-depleted flies were
generated by driving expression of transgenes bearing long hairpin double-stranded
RNA constructs targeting each Toll gene. For Toll (Tl) and Toll-4 through Toll-9, we
crossed control and transgenic flies to a strong ubiquitous driver, Actin-GAL4, to
constitutively express the transgene. Because the Toll-2 (18w) and Toll-3 (Mstprox)
transgenes were lethal when driven ubiquitously during development, we crossed them
to Heat-shock-GAL4 to allow for inducible transgene expression. Once again, silencing
of each Toll was confirmed, although we were unable to detect Toll-3 and Toll-4
expression (Figure S2A). Silenced flies along with their sibling controls were challenged
with VSV and monitored for changes in viral infection at day 6 post infection. Only the
loss of Toll-7 had a significant effect on VSV infection and led to an increase in viral
RNA production (Figure 4A). Furthermore, increased viral replication upon Toll-7
depletion was also observed at day 9 post infection (Figure 4B). To validate the Toll-7
phenotype, we challenged a second independent transgenic RNAi line and similarly
found that silencing of Toll-7 resulted in increased VSV replication as measured by
Northern blot at day 6, as well as at later time points (Figure S2B,C). Finally, adult flies
expressing heat shock-driven Toll-7 dsRNA exhibited increased viral replication,
suggesting that the susceptibility of Toll-7 depleted flies to VSV infection is not due to
developmental defects (Figure S2D).
Because RNAi-mediated silencing is incomplete and Toll-2 was antiviral in cell
culture (Figure 3), we tested whether previously characterized Toll-2 mutant flies (18wΔ735/Df(2R)017

) were more susceptible to VSV infection (128). In contrast to our in vitro results,

Toll-2 was dispensable for defense against VSV in adult flies (Figure S2E). Taken
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together, these data suggest that Toll-7 but not Toll-2 is an essential component of the
antiviral arsenal in both cells and adult flies.
Next, we evaluated whether Toll-7 depletion alters the susceptibility of flies to
VSV infection. Depletion of Toll-7 had no effect on the lifespan of adult flies (Figure 4C).
We challenged control (+> UAS-Toll-7 IR) or Toll-7 depleted flies (Actin-GAL4> UASToll-7 IR) with VSV and found that while the control flies were viable, the Toll-7 depleted
flies succumbed to infection (Figure 4C). Thus, Toll-7 depletion in adult flies promotes
increased viral replication, leading to mortality from an otherwise non-lethal infection.
Although silenced flies exhibited decreased Toll-7 mRNA expression, RNAi
carries potential caveats such as driver overexpression and off-target silencing. To
address these concerns, we obtained a recently reported Toll-7 mutant fly line harboring
a deletion in the Toll-7 coding region (Toll-7g1-5) (236). These flies were crossed to a
deficiency strain to generate flies lacking Toll-7 expression, and we confirmed the
deletion at the DNA level by genotyping and the RNA level by RT-PCR (Figure S2F-H).
Toll-7 mutants and control flies were infected with VSV, and consistent with the in vivo
RNAi results, the Toll-7 mutants demonstrated significantly elevated viral replication
(Figure 4D,E; Figure S2I). This increased viral RNA load correlated with decreased
survival of the Toll-7 mutants after infection (Figure 4F). Collectively, these data further
verify Toll-7 as a critical antiviral factor against VSV in vivo.

VSV infection induces Toll-7 expression but not other canonical signaling
pathways
Drosophila has evolved multiple pathways to defend against invading pathogens,
among which are the Toll, IMD and Jak-Stat pathways (121, 180). Each of these
pathways responds to different invading pathogens and ultimately leads to the induction
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of specific antimicrobial peptides (AMPs) (121). Since all the Drosophila Tolls have a
conserved Toll and Interleukin-1 receptor (TIR) domain (91), we explored whether Toll-7
signals via the canonical Toll signaling pathway. The Toll-dependent AMP gene
Drosomycin is potently activated after fungal infection, but it was only modestly induced
by VSV infection in cultured cells (~2-fold, Figure 5A). To examine whether this induction
reflects a requirement for the Toll signaling pathway in restricting VSV infection in vivo,
we challenged flies mutant for canonical pathway components including the TIR adapter
MyD88 and NF-kB member Dif, which are both essential for fungal and Gram-positive
bacterial immunity in adult flies (16, 93, 208). Loss of these critical Toll pathway
components had no impact on VSV replication in vivo, suggesting that Toll-7 signals
through a distinct pathway (Figure 5B).
The IMD pathway is also activated by a PRR and converges on alternative NFkB transcription factors that induce a different spectrum of AMPs including Diptericin
(121). We also explored this pathway to see if Toll-7 might be signaling through
downstream members and found that VSV infection did not affect Diptericin expression
in cell culture (Figure 5A).
Lastly, we examined the Jak-Stat signaling pathway, which has been shown to
play antiviral roles both in flies and mammals (55, 66). Upon VSV infection of cells, we
found that expression of vir-1, a virus-specific Stat-dependent gene in Drosophila, was
unperturbed (Figure 5A). These data suggest that Toll-7 mediates its antiviral effects
through a signaling cascade distinct from the canonical Toll, IMD or Jak-Stat pathways.
As many genes with roles in immunity are regulated by infection, we examined
the expression of Toll-7 (and the other Toll receptors) after VSV infection. Cells were
challenged with VSV, and Toll-7 along with Toll, Toll-2, Toll-4 and Toll-8 were
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transcriptionally induced, indicating a potential role for these genes in immunity (Figure
5C).

Toll-7 is a surface receptor that interacts with VSV
TLRs can reside either at the plasma membrane or within endosomal
compartments where they interact directly or indirectly with pathogens. Therefore, we
characterized the subcellular localization of Toll-7. For these studies we generated an
antibody that recognizes endogenous Toll-7 and found that RNAi against Toll-7
efficiently depleted the protein in both cells and flies (Figure 6A). Toll-7 protein was also
undetectable in the Toll-7 mutant flies (Figure 6A), and transgenic flies expressing Toll-7
under control of Heat-shock-GAL4 exhibited increased Toll-7 protein, further validating
the antibody’s activity (Figure S3). To test whether Toll-7 is a plasma membrane
resident protein, we surface biotinylated Drosophila cells with a cell impermeable form of
biotin and precipitated the biotinylated proteins with avidin. Similar to the known surface
resident protein Toll, Toll-7 was precipitated by avidin while tubulin, an intracellular
protein, was not found in the precipitate (Figure 6B).
In general, mammalian TLRs bind directly to their PAMPs, while recognition by
Drosophila Toll is indirect. Toll is instead activated by the cytokine spätzle, which is the
product of a proteolytic cascade induced upon upstream recognition of bacterial and
fungal PAMPs (3, 62, 122). Therefore, we tested whether VSV interacted with Toll-7 at
the cell surface. Cells were pre-bound with purified biotinylated infectious VSV at 4ºC to
allow for surface binding. After one hour, unbound virus was removed and cell lysates
were applied to avidin beads. Precipitation of proteins bound to VSV revealed that VSVG was efficiently precipitated, as we were unable to detect the low amount in the input
(Figure 6C). We found that VSV interacted with endogenous Toll-7 at the plasma
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membrane, and that this interaction was lost upon RNAi depletion of Toll-7 (Figure 6C).
Moreover, the interaction between Toll-7 and VSV was specific, as Toll-7 did not bind
biotinylated IgG (Figure 6C,D). Lastly, while Toll-7 precipitated with VSV, the plasma
membrane protein Toll and the intracellular protein tubulin did not precipitate, suggesting
that Toll-7 is a specific and bona fide PRR for VSV (Figure 6D).

VSV-induced autophagy is dependent on Toll-7 in cultured cells
Since both Toll-7 and autophagy show similar antiviral activity against VSV, we
tested whether Toll-7 is the PRR upstream of autophagy. In order to examine
autophagy, we implemented a commonly used assay dependent upon the change in
localization of an expressed GFP-tagged Light Chain 3 (GFP-LC3) in Drosophila cells
(97, 141, 176, 188). Under normal conditions, LC3 shows diffuse cytoplasmic staining;
however, it is translocated to autophagosomes when autophagy is induced, appearing
as bright puncta within the cell (109, 147). Upon VSV infection or starvation, we
observed a significant increase in the number of LC3 puncta per cell compared to control
cells (Figure 7A-C; quantified in Figure 7D and Figure S4). This induction was
dependent on canonical autophagy proteins, as depletion of Atg5, a core component of
this pathway, blocked the puncta formation induced by either VSV infection or starvation
(Figure 7E-G; quantified in figure 7H and Figure S4). In contrast, upon silencing of Toll7, VSV-induced puncta were lost while starvation-induced puncta were unaffected
(Figure 7I-K; quantified in Figure 7L and Figure S4). Taken together, these results
indicate that Toll-7 is specifically required for antiviral autophagy but dispensable for
starvation-induced autophagy.

Toll-7 mediates the antiviral autophagy response in adult flies
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Next, we evaluated whether Toll-7 is required for VSV-induced autophagy in vivo.
To examine autophagy in adult flies, we used a well-characterized assay that takes
advantage of Lysotracker, a marker of acidified compartments, to observe the induction
of late-stage autophagosomes in the fat body, which lacks an acidic pH under normal
conditions (6, 17, 36, 141, 176, 188). Toll-7 silenced flies or sibling controls were
infected with VSV-GFP and dissected three days after infection, at which time the fat
body was removed and stained with Lysotracker. While control flies showed significant
Lysotracker staining in VSV-infected fat body cells, Toll-7 depleted flies exhibited
minimal Lysotracker staining despite extensive viral infection, as monitored by GFP
expression (Figure 8A, quantified in B). Uninfected Toll-7 silenced flies or sibling controls
had little Lysotracker staining of fat body cells (data not shown).
To further verify that Toll-7 is required for the induction of autophagy downstream
of VSV infection in adult flies, we implemented an immunoblot assay. During autophagy,
cytosolic LC3 (LC3-I or Atg8-I) is conjugated with phosphatidylethanolamine, forming a
lipidated form of LC3 (LC3-II or Atg8-II) that decorates the autophagic membrane and
results in a size shift by immunoblot (188). Control flies exhibited a strong induction of
autophagy after VSV infection as monitored by increased Atg8-II amounts; however,
VSV-activated autophagy was severely abrogated in Toll-7 depleted flies (Figure 8C).
Consistent with these results, Toll-7 mutant flies demonstrated a reduction in Atg8-II
production after VSV challenge compared to the controls (Figure 8D). Autophagy was
induced independently of canonical Toll signaling as Myd88 mutant flies showed
substantial Atg8-II accumulation after VSV infection (Figure S5). Together, our results
confirm that Toll-7 is required for VSV-induced antiviral autophagy both in vitro and in
vivo.

43

DISCUSSION
The essential role for Drosophila Toll in antimicrobial defense is firmly
established; however, whether other Toll receptors serve important immune functions
has been poorly understood. We have identified a role for a second Drosophila Toll
receptor, Toll-7, in antiviral defense both in cells and animals. Toll-7 depleted cells
exhibited increased VSV infectivity, and Toll-7 deficient flies demonstrated significantly
elevated viral replication and mortality after VSV challenge. Furthermore, Toll-7 acted as
a PRR by interacting with VSV at the plasma membrane to induce an effector program
that converged on antiviral autophagy. The function of Toll-7 appears to be specific to
antiviral immunity, as Toll-7 deficient flies mount appropriate AMP responses to septic
injury (236).
Multiple innate immune pathways in Drosophila rely on the activation of the
transcription factor NF-kB; however, the Toll-7 dependent autophagy response is likely
elicited via an NF-kB-independent mechanism. Unlike Toll-7 deficient flies, flies lacking
core Toll pathway components did not demonstrate increased susceptibility to VSV.
Moreover, the IMD pathway was not activated by viral infection. In agreement with these
data, MyD88 was also not required for the induction of antiviral autophagy. This NF-kB
independence is consistent with previous studies that found that the NFkB-dependent
AMPs Diptericin and Drosomycin are not induced in Drosophila cells when stimulated
with a hyperactive form of Toll-7 (207) and that Toll-7 is dispensable for immunity to NFkB-dependent bacterial challenges (236). Hence, while Toll-7 likely activates noncanonical signaling pathways, the exact pathways downstream of Toll-7 remain to be
determined.
Recent studies in mammals found that TLR activation can lead to the induction of
autophagy in a variety of cultured cells (50, 181, 192, 235). However, the mechanism by
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which TLR stimulation converges on autophagy is unclear. Moreover, the dependence
on specific signaling molecules is controversial and whether TLR-induced autophagy is
important in restricting infection in vivo is unknown (49, 234). Our data, together with the
findings that Listeria recognition via a peptidoglycan recognition protein induces
autophagy (238), suggest that multiple classes of PRRs are involved in the induction of
antimicrobial autophagy, which plays an important role in the control of a diverse set of
pathogens.
While the discovery of Toll as an innate immune receptor led to the identification
of TLRs as a large family of PRRs, studies demonstrating a role for the additional eight
Toll receptors in immunity have lagged behind. This discrepancy may be in part due to
the lack of studies probing the role of the additional eight Toll receptors in antiviral
defense. Perhaps the lack of classical cytoplasmic sensors (RIG-I and MDA5) has
required Drosophila to be more heavily dependent on the Tolls for viral recognition,
opening up the possibility that additional Drosophila Toll receptors play roles in antiviral
immunity. This hypothesis is further supported by our finding that a number of
uncharacterized Tolls are induced by viral infection similar to the two major antiviral
TLRs, TLR3 and TLR7, which are transcriptionally induced by viral infection in
mammalian systems (198, 203). Importantly, Toll-7 is conserved in vector mosquitoes,
suggesting that Toll-7 and other Toll receptors may be involved in the recognition and
restriction of human arboviruses (220).
TLRs are generally thought to directly bind their PAMPs, whereas Drosophila Toll
functions indirectly by recognizing a host cytokine. Our findings that Toll-7 interacts with
VSV virions suggest that Toll-7 might act directly as a pattern recognition receptor more
similar to mammalian TLRs, a previously unknown mechanism for an insect Toll
receptor. Although VSV is an arbovirus, the natural vectors have been proposed to be
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biting insects such as sand flies and blackflies (41, 142); nevertheless, for several
reasons we believe that VSV is a bona fide ligand for Drosophila Toll-7. First, Toll-7 is
highly conserved between insect species that have been sequenced (66% identity and
77% homology to Aedes aegypti Toll-7), indeed, more so than many other Toll
receptors. Second, while nucleic acids have been well-characterized as viral PAMPs,
emerging evidence suggests that viral proteins including glycoproteins can also activate
TLRs (8, 10). Importantly, there are several examples of murine TLRs that recognize
PAMPs from viruses that naturally do not infect mice. Humans are the natural host of
measles virus, yet the viral hemagglutinin still activates mouse TLR2 (15). Likewise,
Tlr2-/- murine macrophages have reduced cytokine responses to hepatitis C virus core
and NS3, as well as to human cytomegalovirus, despite the fact that both viruses are
human viruses (33, 42). Moreover, in mouse macrophages and myeloid dendritic cells,
VSV-G activates an antiviral response dependent on TLR4, even though VSV does not
normally infect mice in the wild (67). These results are consistent with the idea that
PAMPs are molecular signatures often conserved across wide groups of pathogens and
not necessarily restricted to a single microbe. It is therefore not unexpected that TLRs
(as well as Tolls) can recognize these structures even if they have not yet encountered
that particular pathogen. Third, while the Rhabdovirus VSV does not normally infect fruit
flies, the closely related Rhabdovirus sigma virus is a natural Drosophila pathogen (65).
The Drosophila sigmaviruses phylogenetically cluster more closely to the vesiculoviruses
than other groups of Rhabdoviruses (131). Furthermore, while autophagy has not
formally been shown to restrict sigma virus, flies deficient in Drosophila p62 (ref(2)p),
which serves as an autophagy cargo receptor implicated in the clearance of Sindbis
virus capsids and other pathogens, are more susceptible to infection (44, 57, 163).
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Given the relatedness of sigma virus to VSV, we posit that the Toll-7 ligand on VSV may
be similar to that of a natural Drosophila pathogen.
Intriguingly, the interaction between Toll-7 and VSV suggests that other Toll
receptors may recognize presently undefined ligands, including pathogen-derived
molecules. Taken together with studies on Toll in microbial defense, our data suggest
that Toll receptors likely evolved to recognize foreign microbes and elicit antimicrobial
effector mechanisms, therefore uncovering an evolutionarily conserved intrinsic antiviral
program that links pathogen recognition to autophagy, which may be amenable to
therapeutic intervention.
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Figure 3. Drosophila Toll-7 and Toll-2 are antiviral in cells.
A. Drosophila cells pretreated with dsRNAs against the indicated genes were infected
with VSV (MOI=0.1) for 20 hr and processed for immunofluorescence. Infected cells
express GFP, and the percent infection is calculated with automated image analysis
(MetaXpress) from three wells, with three sites per well (virus, green; nuclei, blue). B.
Percent infection for three experiments is shown; Mean±SE, *p<0.01, Student’s t-test. C.
Cells pretreated with the indicated dsRNAs were infected (MOI=0.1) and processed for
immunoblot 20 hr.p.i; a representative experiment of three is depicted.
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Figure 4. Toll-7 is antiviral in adult flies.
A. Adult flies expressing dsRNA against the indicated Toll receptors were challenged
with VSV and monitored for viral replication at 6 d.p.i. by RNA blot and quantified relative
to a cellular control mRNA (Actin). Fold change of the Mean±SD compared to sibling
controls for three experiments is shown; *p<0.05, Student’s t-test. B. Toll-7 depleted flies
(Actin-Gal4> UAS-Toll-7 IR) or sibling controls (+> UAS-Toll-7 IR) were challenged with
VSV and viral RNA was monitored by RNA blot at the indicated time points p.i. Blot is
representative of three experiments. C.Survival of adult flies expressing dsRNA against
Toll-7 (Actin-Gal4> UAS-Toll-7 IR) or sibling controls (+> UAS-Toll-7 IR) challenged with
vehicle (PBS) or VSV Mean±SE is shown for three experiments (Log-rank test, p<0.02).
D. Toll-7 mutant (Df(2R)BSC22/Toll-7g1-5) or control flies (+/Toll-7g1-5) were infected with
VSV and viral replication was monitored by Northern blot. E. Average fold change of viral
RNA in Toll-7 mutants compared to controls normalized to RpS6 expression at 6 d.p.i;
*p<0.05, Student’s t-test. F. Survival of VSV-challenged Toll-7 mutant
(Df(2R)BSC22/Toll-7g1-5) or sibling control flies (Df(2R)BSC22/+ and +/Toll-7g1-5) for
three experiments (Mean±SE; Log-rank test, p<0.001).
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Figure 5. Toll-7, but not the canonical innate immune signaling pathways, is
transcriptionally induced by VSV infection.
A. Drosophila cells were either uninfected or infected with VSV for four hours and
processed for RT-qPCR of the Toll pathway AMP Drosomycin, the Imd pathway AMP
Diptericin and the Jak-Stat pathway readout vir-1. These were normalized to a control
gene (Rp49) and fold change of Mean±SD for three experiments is shown; *p<0.01,
Student’s t-test. B. Adult flies either heterozygous or homozygous mutant for the Toll
pathway components MyD88 and the NF-kB transcription factor Dif were challenged
with VSV and viral replication was monitored by RNA blot at 6 d.p.i. and quantified
relative to a cellular control (Actin). Fold change compared to heterozygous control of
the Mean±SD for three experiments is shown. C. Expression of the Drosophila Tolls
from VSV-infected cells 4 hr.p.i. compared to uninfected cells was analyzed by RTqPCR; Mean±SD, *p<0.01, Student’s t-test.
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Figure 6. Toll-7 is a membrane-bound receptor that interacts with VSV.
A. Immunoblot of Drosophila cells treated with control or Toll-7 dsRNA (left), adult flies
expressing dsRNA against Toll-7 (Actin-Gal4> UAS-Toll-7 IR) or sibling controls (+>
UAS-Toll-7 IR) (center) and Toll-7 mutant (Df(2R)BSC22/Toll-7g1-5) or control flies
(+/Toll-7g1-5) (right) probed for Toll-7 and control (tubulin). A representative experiment is
shown; similar findings were made in at least three experiments. B. Cells at 4ºC were left
untreated or biotinylated for one hour, and lysates were probed with the indicated
antibodies (input, left; precipitate, right). A representative experiment is shown; similar
findings were made in at least three experiments. C. Drosophila cells treated with the
indicated dsRNA were left untreated or incubated with biotinylated IgG or biotinylated
VSV for one hour at 4ºC. Lysates were precipitated with streptavidin beads and
immunoblotted for Toll-7 or VSV-G. Coomassie staining is shown as a loading control. A
representative experiment is shown; similar findings were made in at least three
experiments. D. Cells were left untreated or incubated with biotinylated VSV for one hour
at 4ºC. Lysates were precipitated with streptavidin beads and immunoblotted with the
indicated antibodies. A representative experiment is shown; similar findings were made
in at least three experiments.
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Figure 7. Toll-7 is required for antiviral autophagy in cell culture.
A-L. Cells transfected with a GFP-LC3 reporter (green) were treated with dsRNA against
a negative control (Betagal), canonical autophagy component Atg5 or Toll-7. Cells were
left uninfected (A,E,I), starved (B,F,J), or infected with VSV for 22 hr (MOI=10) (C,G,K).
Representative images are shown (nuclei, blue; GFP-LC3, green; VSV-G, red). Open
arrows indicate GFP-LC3+ puncta while closed arrows indicate VSV+ cells devoid of
GFP-LC3 puncta. Scale bar, 10 µM. D,H,L. Quantification of the fold change in puncta
per cell for triplicate experiments; Mean±SD is shown; *p<0.02, Student’s t-test.
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Figure 8. Toll-7 is required for antiviral autophagy in adult flies.
A. Control flies (+> UAS-Toll-7 IR) or Toll-7 depleted flies (Actin-Gal4> UAS-Toll-7 IR)
were challenged with VSV-GFP for 3 days. The flies were monitored for infection (GFP+)
and autophagy (Lysotracker+). Representative images of fat body demonstrate that
autophagy is induced in infected wild type cells but not in the infected Toll-7 depleted
cells. Scale bar, 100 µM. B. The percentage of virally infected cells (GFP+) with puncta
(Lysotracker+) was quantified. Mean±SD shown for three experiments; *p<0.0001,
Student’s t-test. C. Immunoblot of control flies (+> UAS-Toll-7IR) or Toll-7 depleted flies
(Actin-Gal4> UAS-Toll-7 IR) challenged with VSV for 2 days. Autophagy was monitored
by size shift of Atg8 (Atg8-II accumulation) and samples were normalized to the control
protein tubulin. These data show representative experiments; similar findings were made
in at least three experiments. D. Immunoblot of Atg8 expression from VSV-challenged
Toll-7 mutant (Df(2R)BSC22/Toll-7g1-5) or control flies (+/Toll-7g1-5) day 3 post infection. A
representative image of three experiments is presented.
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IV. RESTRICTION OF RIFT VALLEY FEVER VIRUS INFECTION BY AUTOPHAGY IS
CONSERVED FROM FLIES TO MAMMALS
1. Background
Autophagy is a fundamental biological process that mediates the breakdown of
cytoplasmic material and is highly conserved from yeast to humans (145). As an
adaptive response to cellular stress such as starvation, autophagy involves the de novo
formation of double membrane-bound vesicles that degrade the engulfed content to
recycle nutrients and maintain energy homeostasis (133). In addition to controlling this
bulk degradation program, autophagy genes have also been co-opted by the innate
immune system to orchestrate cell-autonomous antimicrobial responses against diverse
pathogens, including bacteria, parasites and viruses (52, 126). For example, in
mammalian systems, autophagy has been suggested to restrict viral replication or
pathogenesis during infection with Herpes simplex virus type 1 (HSV-1), Sindbis virus
(SINV) and Chikungunya virus (CHIKV) (96, 120, 162). Thus, pharmacological
manipulation of autophagy has been proposed as an attractive strategy for treating viral
infection, as well as other diseases including neurodegenerative disorders in which
pathogenic protein aggregates are cleared by autophagy (175, 193). That autophagy
protects neurons against both protein aggregates and viruses suggests potential tissuespecific roles for this pathway. Nevertheless, a better understanding of how autophagy is
regulated during infection is critical to harness this pathway for therapeutic purposes.
Emerging data suggest that pattern recognition receptors (PRRs) can regulate
autophagy activation. These receptors detect widely conserved microbial signatures
known as pathogen-associated molecular patterns (PAMPs) to elicit protective effector
responses (3). Viruses can be recognized at the cell surface or in endosomal
compartments by Toll-like receptors (TLRs), which were originally identified through
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homology to Drosophila Toll (122, 213). Intracellular sensors such as retinoic acidinducible gene-1 (RIG-I) and melanoma differentiation-associated protein 5 (MDA-5),
which are collectively termed RIG-I-like receptors (RLRs), can also detect viral nucleic
acids in the cytoplasm (132). Interestingly, canonical ligands for TLRs (including TLR1/2,
TLR2/6, TLR3, TLR4, TLR5, TLR7 and TLR8) can induce autophagy in macrophages
(25, 50, 190, 235). However, the role of PRR-mediated autophagy in mammals, across
diverse cell types and during viral infection has remained largely unexplored.
Taking advantage of the simplified immune system of Drosophila, recent studies
have provided critical insights into the significance of this PRR-autophagy axis in host
defense against bacteria and viruses (152, 238). In flies, autophagy is triggered by
infection with Vesicular stomatitis virus (VSV), and this response is essential for
controlling viral replication and limiting lethality (188). Toll-7 is the PRR that recognizes
VSV to elicit antiviral autophagy (152). This receptor, along with several other Toll
receptors, is rapidly induced transcriptionally by VSV infection, suggesting broader roles
for the Drosophila Tolls in immunity (232). Yet it remains unclear if Toll receptors and/or
autophagy restrict other viruses, especially those that are more pathogenic in humans,
and whether this TLR-autophagy response to virus is conserved in mammals during
bona fide infection.
By screening Toll receptor mutants for antiviral functions, we have identified a
role for Toll-7 in controlling Rift Valley fever virus (RVFV), a reemerging pathogen that
causes disease in both humans and agriculturally important animals. RVFV is a member
of the family Bunyaviridae, one of the three major classes of arthropod-borne viruses
(arboviruses) that infect humans (219). The virus is transmitted to humans by
mosquitoes, as well as though contact with infected animals. Though RVFV infection in
humans typically causes a self-limiting febrile illness, the liver is a major target of
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infection, with ~50% of infected humans presenting with jaundice. A subset of patients
develop more severe manifestations such as hemorrhagic fever and encephalitis with
neurons as the primary target, and recent outbreaks have been particularly deadly (90).
Livestock are exceptionally susceptible to infection, and mortality rates approach 100%
in newborn animals. Furthermore, while historically RVFV has been limited to subSaharan Africa, the virus has recently spread and can potentially be weaponized.
Importantly, vaccines and therapeutics are unavailable for RVFV, necessitating
additional insight into the pathogenesis and immunologic control of the virus.
We found that Toll-7 mutant flies are more susceptible to RVFV infection due to a
defect in virus-triggered antiviral autophagy, which is essential for controlling viral
replication and survival in flies. Remarkably, the role of antiviral autophagy and its
regulation by PRRs is conserved in mammalian cells during RVFV infection. RVFV
infection activated autophagy in murine and human cells, and loss of autophagy genes
resulted in significantly enhanced viral replication. The TLR signaling adapter MyD88
restricted RVFV infection in mammalian cells and was also required for anti-RVFV
autophagy, suggesting a clear parallel whereby both Drosophila Tolls and mammalian
TLRs direct antiviral autophagy. Importantly, using pharmacologic activation of
autophagy, we were able to potently inhibit RVFV infection in mammalian cells, including
primary hepatocytes and neurons, cell types that are targeted during pathogenic RVFV
infection of humans. Therefore, autophagy activation may be a particularly effective
strategy for treating RVFV and other viral infections, especially neurotropic and
hepatotropic pathogens that target tissues in which autophagy is highly active.

2. Results
Toll-7 restricts RVFV replication in adult flies
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Toll-7 is essential for antiviral defense against VSV in flies, but whether
Drosophila Toll receptors restrict the replication of other viruses has not been
extensively addressed. Flies encode nine Toll receptors, most of which are poorly
characterized. Therefore, we screened a subset of these receptors (Toll, Toll-2, Toll-6,
Toll-7, Toll-8, Toll-9) for antiviral functions in vivo by challenging mutant flies with RVFV.
From these studies, we identified a critical and specific role for Toll-7 in limiting
susceptibility to RVFV infection. Compared to sibling control flies, heteroallelic Toll-7
mutant flies (Df(2R)BSC22/Toll-7g1-5) that express no Toll-7 (236) exhibited significantly
diminished survival after infection with the attenuated MP12 strain of RVFV (Figure 9A).
The increased mortality of RVFV-infected Toll-7 mutant flies was associated with
elevated RVFV titers (Figure 9B). Furthermore, loss of Toll-7 increased levels of RVFV
RNA (both S segment genomic RNA and N mRNA) (Figure 9C,D). These data
collectively suggest that Toll-7 is required for resistance to RVFV infection in vivo.
Restriction of RVFV replication is specific for Toll-7. Flies lacking Toll-8 showed
no change in lifespan after RVFV infection (Figure S6A) and demonstrated similar viral
titers and RNA levels compared to control flies (Figure S6B,C). Likewise, mutants in Toll,
Toll-2, Toll-6 and Toll-9 were not more susceptible to RVFV challenge (Figure S6D-G),
suggesting that these Toll receptors are dispensable for host defense during RVFV
infection. Moreover, we did not observe any change in survival for Toll-7 mutants after
infection with Drosophila C virus (DCV), Flockhouse virus (FHV) or SINV (Figure S6H-J),
and Toll-7 mutant flies harbored equivalent DCV protein levels compared to sibling
control flies (Figure S6K). Toll-7 is also dispensable for induction of antimicrobial
peptides after bacterial infection (236). Taken together, these data reveal that RVFV is
specifically restricted by Toll-7, which is required to limit viral replication and mortality in
adult organisms.
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To complement these loss-of-function studies, we next determined if
overexpression of Toll-7 impacts viral infection. We crossed flies bearing a Toll-7
transgene under control of a UAS promoter element to Heat-shock-GAL4 to allow for
inducible Toll-7 expression in the adult fly. These flies exhibit robust Toll-7 expression
after heat shock induction (152). Compared to control flies lacking the transgene, Toll-7overexpressing flies showed modestly enhanced survival after RVFV infection (Figure
9E). The protective effect of Toll-7 overexpression correlated with significantly
decreased viral RNA levels (Figure 9F,G). In contrast, overexpression of other Toll
receptors did not reduce mortality during RVFV infection (Figure S6L), indicating a
specific interaction between RVFV and Toll-7. Further supporting this specificity, Toll-7
overexpression also did not limit lethality after infection with other viruses, such as DCV,
SINV and FHV (Figure S6M, data not shown). Thus, both loss-of-function and gain-offunction studies demonstrate that Toll-7 is an essential component of Drosophila antiviral
defense against RVFV infection in vivo.
To determine if Toll-7 functions as a PRR for RVFV, we pre-bound biotinylated
purified RVFV virions to the surface of Drosophila cells in the cold to allow surface
binding but no internalization, and precipitated the virus using streptavidin. Biotinylated
RVFV efficiently precipitated endogenous Toll-7, suggesting that RVFV and Toll-7
physically interact at the cell surface, whereas we observed no binding between Toll-7
and control IgG-biotin (Figure 9H). Moreover, biotinylated RVFV did not pull down Toll,
demonstrating that the interaction between Toll-7 and RVFV is specific (Figure 9H).
Therefore, similar to VSV, RVFV particles, which only contain the viral glycoproteins on
the surface, act as functional ligands for Toll-7.

Toll-7-dependent antiviral autophagy is required for host defense in flies
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We next examined the mechanism by which Toll-7 controls antiviral immunity
during RVFV infection. As Toll-7 is required for VSV-induced antiviral autophagy (152),
we hypothesized that RVFV infection engages a similar autophagic pathway through
Toll-7. We evaluated whether RVFV infection activates autophagy in vivo using two
independent methods. During autophagy, cytosolic Atg8-I (the Drosophila homolog of
mammalian LC3) is conjugated to a phosphatidylethanolamine lipid moiety, and this form
(Atg8-II) is recruited to autophagosomal membranes and serves as a marker for
autophagy (188). An elevation in Atg8-II (or LC3-II) expression after a particular stimulus
reflects autophagy activation. Wild-type (WT) flies were challenged with RVFV and
endogenous Atg8 expression was monitored by immunoblot. Compared to uninfected
control flies, RVFV-infected flies showed increased Atg8-II, suggesting that RVFV
infection induces autophagy in vivo (Figure 10A). In contrast, DCV and SINV infection
did not promote Atg8-II conversion in flies (Figure S7A,B). To further explore whether
RVFV activates autophagy, we also monitored flies that express green fluorescent
protein (GFP)-tagged Atg8a in the adult female fat body, the functional equivalent of the
mammalian liver and an important site of viral replication during many arbovirus
infections, including RVFV infection (48, 188) (data not shown). Under basal conditions,
GFP-Atg8a is normally dispersed, but upon autophagy activation, forms discrete puncta
that correspond to autophagosomes (183). While GFP-positive puncta were largely
absent in fat bodies from uninfected flies, fat bodies from RVFV-infected flies showed a
significant increase in cells containing GFP-positive foci (Figure 10B,C). Collectively,
these results suggest that RVFV infection elicits an autophagic response in vivo.
To determine if RVFV-induced autophagy limits susceptibility to viral infection, we
silenced a core autophagy gene (Atg18) using established in vivo RNAi transgenic flies
that were previously used to demonstrate a role for autophagy against VSV (188).

59

Compared to sibling control flies, Atg18-depleted flies showed greatly enhanced lethality
after RVFV infection (Figure 10D). Moreover, silencing Atg18 specifically in the fat body
resulted in significantly increased RVFV RNA levels (Figure 10E,F). We additionally
observed that depletion of other core autophagy genes (Atg5 and Atg7) also increased
viral replication (Figure S7C). Therefore, autophagy genes are critical for resistance to
RVFV infection in adult flies.
We next tested the role of Toll-7 in controlling RVFV-induced autophagy in vivo.
Consistent with our findings in WT flies, flies heterozygous for Toll-7 exhibited an
increase in Atg8-II protein after RVFV infection, indicating that autophagy has been
activated (Figure 10G). However, Atg8-II induction was abrogated in Toll-7 mutant flies,
suggesting that Toll-7 is required for autophagy activation in response to RVFV infection.
Conversely, Toll-7 overexpression enhanced the increase in Atg8-II post-infection,
demonstrating that the level of Toll-7 expression positively correlates with the level of
RVFV-elicited autophagy activation (Figure 10H).
VSV infection in Drosophila attenuates PI3K/Akt signaling, which activates the
antiviral autophagy program (188). To evaluate whether RVFV infection similarly
represses this pathway, we monitored phospho-Akt expression upon infection. Because
the resting levels of phospho-Akt are not detectable, we pretreated flies with insulin to
increase the basal levels of phospho-Akt and challenged them with RVFV. Under these
conditions, we found that RVFV-infected flies showed reduced phospho-Akt levels
compared to uninfected control flies with no decrease in total Akt levels (Figure 10I),
demonstrating that RVFV infection also inhibits Akt signaling to regulate antiviral
autophagy in vivo.
Given that Toll-7-dependent autophagy restricts RVFV replication, we next
determined if pharmacologic activation of autophagy protects against infection. Across
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species, autophagy is regulated by the canonical nutrient signaling pathway whereby the
conserved kinase Tor inhibits the initiation of autophagy (145). As such, drugs that inhibit
Tor (such as rapamycin) are classically used to activate autophagy by relieving this
block. We supplemented fly food with 100 µM rapamycin, a dose that has been used
previously (19). Rapamycin treatment activated autophagy as shown by increased Atg8II conversion compared to flies fed vehicle-treated control food (Figure S7D). Consistent
with a role for autophagy in controlling RVFV replication, rapamycin fed flies
demonstrated significantly reduced viral RNA levels compared to control flies (Figure
10J,K). We next determined if pharmacologically-induced autophagy could suppress the
increased virus replication in Toll-7 mutant flies. As expected, vehicle fed Toll-7 mutant
flies showed increased viral RNA levels compared to sibling control flies (Figure 10L).
Strikingly, rapamycin treatment dramatically reduced viral RNA levels in Toll-7 mutants
to that of control flies. Thus, rapamycin treatment protects against RVFV infection and
bypasses the requirement for Toll-7 in limiting virus replication. Together, these data are
consistent with a role for Toll-7 in orchestrating a protective antiviral autophagy response
during RVFV infection in vivo.

Conserved roles for autophagy in mammalian antiviral defense against RVFV
Previous studies have examined the role of mammalian autophagy during
infection with several viruses including VSV, whose replication is normally restricted by
autophagy in flies (161, 162, 188, 205). VSV can induce autophagy in murine and
human cell lines, as well as in mouse macrophages and plasmacytoid dendritic cells
(119, 205). Despite this robust activation, inhibition of autophagy does not result in
increased VSV replication in the cell types tested, which has been attributed to the role
of autophagy in attenuating RLR-signaling and thus Type I interferon (IFN-I) production.
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However, a role for autophagy in RVFV infection of mammalian cells has not been
explored.
To determine whether autophagy restricts RVFV infection in murine cells, we
examined mouse embryonic fibroblasts (MEFs) genetically null for Atg5, an essential
and conserved autophagy gene (114). As expected, Atg5-/- MEFs were deficient in LC3
processing in response to treatment with rapamycin, an activator of autophagy, and
chloroquine, which inhibits late stages of autophagy and allows for LC3-II accumulation
(Figure 11A). We challenged Atg5-/- MEFs and WT control MEFs with RVFV and
monitored viral infection by plaque assay. In comparison to WT cells, Atg5-/- MEFs
exhibited a significant increase in viral titers (Figure 11B). By contrast, we observed no
difference in viral titers with VSV, suggesting a specific role for mammalian Atg5 in
restricting RVFV infection (Figure 11C). Furthermore, Atg5-/- cells also exhibited
increased RVFV but not VSV by immunofluorescence (Figure 11D-F). Thus, Atg5 is
critical for restricting RVFV infection in murine cells, revealing the first example of a virus
whose replication is restricted by autophagy genes in both Drosophila and mammalian
hosts.
As Atg5 is required for canonical autophagy, we next assessed whether RVFV
infection induces autophagy in MEFs. Infection of WT MEFs with RVFV resulted in the
accumulation of processed LC3-II, suggesting that RVFV infection elicits autophagy in
these cells (Figure 11G). This activation is dependent on Atg5 because Atg5-/- MEFs
exhibited no increase in LC3-II levels after RVFV infection. To determine if RVFV
induces autophagic flux, we monitored the expression of the autophagy adaptor p62 by
immunoblot. p62 recruits cytoplasmic components to autophagosomes and is
consequently degraded upon autophagy activation. Therefore, a decrease in p62
expression denotes flux through the autophagy pathway (147). We found that RVFV
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infection in WT MEFs dramatically reduced p62 protein expression compared to
uninfected cells, and this decrease was not observed in Atg5-/- MEFs (Figure 11H). UVinactivated virus also decreased p62 levels, demonstrating that RVFV-activated
autophagy is stimulated by a component of the incoming virions, and that the induction
cannot be attributed to viral replication products or indirect effects due to altered cellular
demands during infection (Figure 11I). To further assess the conservation between flies
and mammals, we also tested whether RVFV sensing leads to attenuation of Akt
signaling in mammalian cells. Indeed, MEFs incubated with UV-inactivated virus showed
substantially reduced phospho-Akt levels without decreasing total Akt levels, suggesting
conserved regulation of antiviral autophagy by the Akt pathway in both flies and
mammals (Figure 11J). Together, these data show that autophagy is activated in MEFs
to defend against RVFV infection.

Autophagy genes are essential for restricting RVFV replication in human cells
To extend our findings to human cells, we next assessed whether RVFV infection
activates autophagy in a human osteosarcoma cell line (U2OS cells). We monitored
autophagy activation by examining U2OS cells stably expressing a mCherry-GFPtagged LC3 reporter; the GFP tag is acid-insensitive whereas the mCherry tag is acidinsensitive, and thus mCherry+GFP+ puncta represent early autophagosomes while
mCherry+GFP- puncta represent autolysosomes. LC3 puncta accumulate upon treatment
with rapamycin and chloroquine, with chloroquine primarily leading to mCherry+GFP+
puncta due to a blockage of autophagosomal acidification (Figure S8A,B). We observed
a significant increase in LC3 puncta (mCherry-positive) after RVFV infection (Figure
12A,B), suggesting that RVFV infection induces the generation of autophagosomes.
Furthermore, UV-inactivated RVFV also elicited an increase an LC3-puncta, which were
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preferentially mCherry+GFP-, demonstrating that UV-RVFV triggers autophagic flux
(Figure 12A,B and Figure S8B). Moreover, RVFV infection resulted in diminished p62
protein levels (Figure12C,D), further indicating the ability of RVFV to activate autophagy
in human cells.
To define the importance of autophagy activation during RVFV infection of U2OS
cells, we silenced autophagy genes using small interfering RNA (siRNA) technology.
Depletion of Atg5, Atg7 and Beclin 1 resulted in greatly reduced protein expression
(Figure 12E) and functional inhibition of autophagy as shown by decreased LC3-II
accumulation after rapamycin or chloroquine treatment compared to control knockdowns
(Figure S8C,D). Compared to control siRNA-treated U2OS cells, cells treated with
siRNAs against Atg5, Atg7 and Beclin 1 exhibited significantly elevated viral RNA levels
after RVFV infection (Figure 12F,H). In addition to these genes, siRNA-mediated
silencing of Atg13 and Fip200, members of the canonical autophagic preinitiation
complex, also increased viral RNA levels (Figure 12G,H). These data show that multiple
stages of the core autophagy pathway are required for antiviral defense against RVFV,
and thus the role of autophagy genes in restricting RVFV infection is conserved from
flies to humans.

The TLR adapter MyD88 restricts RVFV infection and promotes antiviral
autophagy
Several reports indicate that different viruses can trigger autophagy in
mammalian cells; however, the mechanisms by which viral infection activates autophagy
remain poorly defined. Our experiments in flies suggest the PRR Toll-7 recognizes
RVFV to activate antiviral autophagy. Thus, we postulated that a PRR and downstream
signaling pathway is required for RVFV-induced antiviral autophagy in mammalian cells.
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We first examined the role of RLRs since these function as cytosolic PRRs that detect
viral RNA species such as double-stranded RNA and 5’-triphosphorylated RNA to
potently restrict many RNA viruses (132). Moreover, RVFV genomic RNAs, which
contain a 5’-triphosphate, can trigger RIG-I signaling (73). Since mitochondrial antiviralsignaling protein (MAVS) is a common signaling adapter for the two canonical RLRs,
RIG-I and MDA5, we tested MAVS-/- MEFs (53). Consistent with a known role for RIG-I
in sensing VSV (103), MAVS-/- MEFs demonstrated significantly increased VSV titers
compared to WT MEFs (Figure S9A). Perhaps surprisingly, we found no difference in
RVFV titers between MAVS-/- and WT MEFs, suggesting that RLR-mediated signaling is
dispensable for restricting RVFV infection in this cell type (Figure S9B). Similar results
were found when monitoring VSV and RVFV infection in MAVS-/- MEFs by
immunofluorescence (Figure S9C-E). In addition, MAVS is dispensable for RVFVinduced autophagy as p62 protein levels decreased to a similar extent in MAVS-/- MEFs
and WT MEFs after RVFV infection (Figure S9F). We also examined the role of TANKbinding kinase-1 (TBK1), which functions downstream of RLRs (and certain endosomal
TLRs such as TLR3) and is essential for antimicrobial autophagy against some bacteria
including Mycobacterium tuberculosis (64, 221). Compared to WT MEFs, TBK1-/- MEFs
exhibited increased infection with VSV but not RVFV, as well as normal p62 degradation
in response to RVFV infection (Figure S9G-L). Consequently, neither TBK1 nor MAVS is
required for RVFV-induced antiviral autophagy in MEFs.
In addition to detecting viral nucleic acids in the cytosol, cells also recognize
viruses at the plasma membrane or in endosomal compartments via TLRs. Furthermore,
TLR engagement by canonical ligands can activate autophagy in macrophages (50,
235). Since Toll-7 is required for RVFV- and VSV-induced antiviral autophagy in flies
(152), we examined whether TLRs are involved in RVFV-induced autophagy in
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mammalian cells. TLRs signal through two downstream TIR domain-containing
adapters, MyD88 and TRIF (158). To determine if either TIR adapter restricts RVFV
infection, we silenced MyD88 and TRIF in U2OS cells using siRNAs and verified robust
knockdown by immunoblot (Figure 13A). Compared to U2OS cells transfected with
control siRNA, U2OS cells transfected with MyD88-specific siRNA showed significantly
increased RVFV infection by immunofluorescence (Figure 13B,C). The increase in
percent infection with MyD88 silencing was equivalent to the increased RVFV infection
observed with Beclin 1 knockdown (Figure 13B,C). In contrast, we found no change in
infection with TRIF depletion, suggesting that MyD88 but not TRIF mediates cell-intrinsic
antiviral immunity to RVFV (Figure 13B,C). Moreover, MyD88-silenced cells
demonstrated significantly increased RVFV RNA replication (Figure 13D,E), further
indicating that MyD88 restricts RVFV infection in human cells.
To validate the antiviral role of MyD88 in RVFV infection, we also tested MyD88-/MEFs (205). Consistent with our results in human cells, RVFV-challenged MyD88-/MEFs showed a significant increase in viral titers, similar to the increase observed in
ATG5-/- MEFs (~10-fold, Figure 13F). These data further implicate MyD88 as a critical
component in mammalian host defense against RVFV infection.
In control siRNA-treated U2OS cells, RVFV infection increased the percentage of
cells containing LC3 puncta (Figure 13G,H). Importantly, RVFV-triggered
autophagosome formation was Atg5-dependent, as silencing of Atg5 abrogated this
response. While TRIF was dispensable for RVFV-triggered autophagy, MyD88-silenced
cells showed a significant decrease in RVFV-induced LC3 puncta compared to control
cells (Figure 13H). Moreover, compared to WT MEFs, MyD88-/- MEFs demonstrated
impaired LC3-II accumulation and p62 degradation induced by RVFV infection (Figure
13I,J). This defect was not due to a general requirement for MyD88 in autophagy since
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MyD88 silencing had no impact on LC3-II accumulation induced by rapamycin or
chloroquine (Figure S9M). These data suggest that antiviral autophagy against RVFV is
MyD88-dependent in both human and mouse cells.

TRAF6 regulates antiviral autophagy against RVFV infection
Previous studies have shown that the E3 ubiquitin ligase tumor necrosis factor
receptor-associated factor 6 (TRAF6) regulates LPS-induced autophagy, which partly
depended on MyD88 in these experiments (190, 191). Therefore, because we identified
a role for MyD88 in RVFV-elicited autophagy, we tested the requirement for TRAF6.
RNAi-mediated depletion of TRAF6 was efficient in U2OS cells and markedly increased
RVFV protein and RNA levels (Figure 14A-C). This defect in virus control with TRAF6
knockdown was associated with a significant reduction in UV-RVFV-induced LC3 puncta
similar to Atg5 and MyD88 silencing (Figure 14D), suggesting that TRAF6 promotes
RVFV-associated autophagy in human cells. Thus, TRAF6, which is known to act
downstream of MyD88 in TLR signaling pathways, is necessary for activating autophagy
to control RVFV replication.
Flies encode three members of the TRAF family: Traf6, Traf4 and Traf-like.
Therefore, to further understand conserved signaling pathways that regulate antiviral
autophagy, we next assessed the role of Drosophila Traf6. Previous work has proposed
that dTraf6 is a component of the canonical Toll signaling pathway (189), although other
functions in immunity remain to be determined. To determine if dTraf6 restricts RVFV
infection in vivo, we challenged previously characterized dTraf6 mutant flies
(dTraf6Exo1/dTraf6Exo1) (30) or heterozygous controls with RVFV and found that dTraf6
mutant flies showed significantly increased viral RNA levels, indicating that dTraf6
controls RVFV infection in adult organisms (Figure 14E,F). Further, dTraf6 mutants
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showed impaired autophagy activation during RVFV infection as assessed by Atg8
immunoblot (Figure 14G). Taken together, these data demonstrate a requirement for
TRAF6 in antiviral autophagy in both flies and mammals, revealing additional conserved
components of this innate defense pathway.

Autophagy-activating drugs protect against RVFV infection in mammalian cells
There are no specific therapeutics against RVFV infection, leading to high
mortality during outbreaks (90). Since rapamycin inhibits RVFV infection in flies and
autophagy genes potently restrict RVFV replication in mammalian cells, activating this
pathway may offer a novel strategy to treat RVFV infection in humans. Therefore, we
investigated whether autophagy-inducing drugs protect against RVFV infection in human
and mouse cells. In addition to testing rapamycin, which inhibits the autophagyconstraining kinase mTor, we also evaluated the protective effect of small molecule
enhancer of rapamycin (SMER)28, a recently developed autophagy inducer that acts
independently of mTor by an Atg5-dependent mechanism (182). As expected, treatment
of U2OS cells with rapamycin or SMER28 activated autophagy as measured by
increased LC3 puncta formation that was dependent on Atg5 (Figure S10A,B).
To determine if autophagy-activating drugs protect against RVFV infection, we
pretreated MEFs with rapamycin or SMER28 and then infected with RVFV. Both
rapamycin and SMER28 treatment dramatically reduced the percentage of RVFVinfected cells (Figure 15A). This inhibitory effect was dose dependent for rapamycin
(Figure 15B) and SMER28 (Figure 15C), with IC50 values within previously reported
ranges (157, 182). Both drugs also protected against RVFV infection in human U2OS
cells (Figure 15D-F), and this antiviral effect was specific for RVFV, as we observed no
inhibition of VSV or SINV infection, consistent with previous findings that VSV and SINV

68

replication is insensitive to rapamycin treatment (Figure 15G,H) (43, 148). Thus, these
data suggest that chemical modulation of autophagy can selectively limit RVFV
replication in mammalian cells.
To further demonstrate the therapeutic antiviral potential of autophagy inducers,
we next asked whether these drugs play a protective role in primary cells from tissues
targeted by RVFV during natural infection. RVFV is highly hepatotropic, and infection
can progress to fulminant hepatitis in a subset of human patients (90). Indeed, in mice,
the liver is the major target organ of RVFV and productive virus can be detected in the
liver by day two post-infection (71). Considering the paramount role of liver infection in
RVFV pathogenesis, we examined if autophagy-inducing drugs control RVFV infection in
primary mouse hepatocytes. RVFV infection induced autophagy in hepatocytes as
measured by increased LC3-II and decreased p62 expression (Figure 16A). Strikingly,
both rapamycin and SMER28 treatment dramatically reduced viral RNA levels (Figure
16B), indicating that autophagy inducers also have powerful antiviral activity in
hepatocytes. We observed no increase in induction of the interferon-stimulated gene
Isg56 in infected rapamycin-treated cells, and Isg56 expression was lower in SMER28treated cells; thus, the protective effect of autophagy-activating drugs likely cannot be
explained by an exaggerated IFN-I response (Figure 16C).
Though most patients clear acute RVFV infection, some patients develop severe
neurological disorders and encephalitis, suggesting that RVFV is neuroinvasive (90).
Moreover, in animal models of RVFV infection, mice that survive acute infection can
develop encephalitis similar to human cases, and viral antigen can be detected in a wide
variety of neuronal cell types in the brain (174). We consequently asked if autophagy
activation also protects neuronal cells against RVFV infection. Importantly, SMER28
treatment promoted the clearance of pathogenic protein aggregates in several models of

69

neurodegenerative disease, including in primary rat neurons, demonstrating no toxicity in
these cells (182, 211). To determine the antiviral activity of autophagy inducers in
neurons, we tested if rapamycin and SMER28 inhibit RVFV infection in primary rat mixed
neuroglial cultures, which were comprised of approximately 75% neurons (data not
shown). Both SMER28 and rapamycin induced autophagy in neuronal cultures as shown
by increased LC3-II accumulation and p62 degradation (Figure 16D). Neuronal cultures
were pretreated with SMER28 or vehicle control prior to infection with RVFV, and
infection was monitored by microscopy. Remarkably, whereas the majority of cells were
infected in control cultures, SMER28-treated cells were largely protected from infection
(Figure 16E). Image analysis showed that SMER28 significantly decreased the percent
of RVFV-infected cells by approximately 80% (Figure 16F). Co-staining for microtubuleassociated protein 2 (MAP2), a neuronal differentiation marker, revealed that while
neurons were efficiently infected by RVFV in control cultures, non-neuronal cells were
disproportionately infected in SMER28 cultures, indicating that the SMER28 is
particularly protective in neurons (Figure 16G). This dramatic inhibition of viral replication
was also observed when monitoring viral RNA levels, as SMER28 treatment resulted in
a 95% reduction in RVFV RNA (Figure 16H). We also observed inhibition of RVFV
infection with rapamycin treatment, albeit more modestly (Figure 16H). Notably, RVFV
infection activated autophagy in neuroglial cultures as shown by robust p62 degradation
and elevated LC3-II levels (Figure 16D), suggesting that autophagy activation is a
normal response to RVFV infection in neuronal cells. Collectively, these data suggest
that pharmacologic activation of autophagy protects hepatocytes and neurons against
RVFV infection and may be a promising treatment strategy for RVFV-induced hepatitis
and encephalitis.
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3. Discussion
Autophagy is an ancient host response to starvation that has emerged as an
important facet of the innate immune arsenal. The breadth of pathogens that engage this
pathway, as well as the mechanisms by which it is regulated during infection, is just
beginning to be understood. We found that in both flies and mammals, autophagy genes
restrict the replication of RVFV, a medically and agriculturally important arbovirus for
which there is no effective treatment or vaccine. Importantly, intervention with
autophagy-activating pharmacological agents potently blocks infection. Therefore, this
study reveals critical insights into the mechanisms regulating antiviral autophagy and
offers a potential avenue for developing novel RVFV-directed treatments.
By screening Drosophila Toll receptors for antiviral functions, we have extended
the scope of the antiviral Toll receptor-autophagy axis to RVFV. Toll-7 mutant flies
succumb to RVFV infection, whereas transgenic flies that overexpress Toll-7 are
protected against mortality, but not with a panel of other viruses. Moreover, Toll-7
interacted with purified RVFV virions, suggesting that Toll-7 is a bona-fide PRR that
likely recognizes surface-exposed glycoproteins. The PAMP is consequently similar to
that of VSV, which is also recognized via its glycoprotein to activate autophagy (152).
Viral infection in Drosophila cells triggers the rapid induction of antiviral genes and
multiple Toll receptors (Toll, Toll-4, Toll-7 and Toll-8) (232). While we found no role for
additional Toll receptors in RVFV infection, these receptors may function in unknown
contexts, perhaps with distinct pathogens that have not been tested. Indeed, a recent
study showed that Toll-8 is an important negative regulator of antimicrobial peptide gene
expression in larval respiratory epithelia (2). Together, these findings suggest that Toll
receptors evolved as critical components of host defense and immune regulatory
pathways.
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We found that Toll-7 exerts its antiviral activity against RVFV by activating
autophagy, as Toll-7 is necessary for RVFV-induced autophagy in vivo, and silencing of
autophagy genes leads to increased mortality and viral replication. Remarkably, the role
of autophagy genes in protecting against RVFV is conserved in mammalian cells. RVFV
triggered autophagy in mouse, rat and human cells, including primary hepatocytes and
primary neurons. This activation is essential for restricting infection, as RVFV replication
was enhanced by both loss of Atg5 in MEFs and knockdown of several core autophagy
genes in human U2OS cells. While recent studies show that diverse viruses can trigger
autophagy, the ability of autophagy to limit viral replication is complicated. For example,
while neuron-specific deletion of Atg5 increases lethality after SINV infection, viral titers
are not generally affected, indicating that autophagy does not restrict SINV replication
per se (162). Wild-type HSV-1 is also not normally restricted by autophagy, as it
encodes a virulence factor ICP34.5 that inhibits autophagy through two known
mechanisms: blocking protein kinase R-dependent autophagy and binding to Beclin 1
(161, 206). Both proviral and antiviral functions have also been reported for autophagy in
CHIKV infection (96, 113). Thus, our data suggest that autophagy may play a more
direct role in restricting RVFV replication than other viruses previously studied. The
importance of this host response in RVFV infection is underscored by its evolutionary
conservation between flies and mammals.
Recent studies have raised a distinction between autophagy as a pathway and
autophagy genes that may have distinct functions outside of canonical autophagy. For
example, restriction of mouse norovirus replication by interferon-γ requires the Atg5Atg12/Atg16L1 complex but not the downstream gene Atg4B or lysosomal degradation,
and Atg5 restricts T. gondii replication without the requirement for autophagosome
generation (87, 245). Furthermore, other autophagy-related processes utilize autophagy
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genes, such as LC3-associated phagocytosis, which involves rapid LC3 recruitment to
the phagosome (181). As there are no specific genes for these autophagy-like
processes, their distinction is in part based on the formal demonstration that certain
“cassettes” of autophagy genes are required while others are dispensable. We show that
genes involved in multiple stages of autophagy restrict RVFV replication, from the
preinitiation complex (i.e. Atg13 and Fip200) to the elongation phase (i.e. Atg5 and
Atg7). Thus, canonical autophagy likely restricts RVFV infection, although the exact
mechanism by which autophagy exerts its antiviral properties remains to be determined
in future studies.
While much work has demonstrated that pathogens can trigger autophagy,
relatively little is known about the mechanisms that activate antimicrobial autophagy,
especially during viral infection. Recent studies suggest that PRRs such as mammalian
TLRs can regulate autophagy in response to canonical ligands (25, 50), but the role of
PRRs in activating autophagy during viral infection has not been thoroughly investigated.
Surprisingly, we found no role for MAVS in restricting RVFV infection, although a recent
report identified a key function for MAVS signaling in RVFV-elicited IFN-I responses in
murine dendritic cells and macrophages, and another study showed that nucleocapsidassociated RVFV RNA activates RIG-I (60, 225). The contrasting role of MAVS may be
related to cell-type specific functions for autophagy and PRRs. Indeed, MAVS does not
restrict RVFV replication in macrophages even though it regulates IFN-I expression,
suggesting that at a cell-intrinsic level, IFN-I alone cannot explain RVFV control.
Moreover, RVFV encodes an interferon antagonist (NSs), and therefore other restriction
mechanisms besides IFN-I must exist (21). Our data provide evidence that perhaps
autophagy and not IFN-I is the major antiviral pathway against RVFV in some cell types.
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Since MAVS does not restrict RVFV replication in MEFs, we next focused on the
classical TLR signaling adapters MyD88 and TRIF, which have both been implicated in
TLR ligand-induced autophagy, although the exact mechanism is not fully understood
(190, 191, 235). Interestingly, MyD88 but not TRIF was required to restrict RVFV
infection and elicit anti-RVFV autophagy. Thus, TLR-mediated signaling has an
evolutionarily conserved role in directing antiviral autophagy and host defense from flies
to mammals. The specific TLR required for RVFV-induced autophagy remains unknown.
U2OS cells express all TLRs but TLR8, and MEFs express TLRs 1-9 (116, 187). Given
that TRIF and TBK1 do not restrict RVFV infection, we hypothesize that a plasma
membrane TLR acts as the upstream autophagy-activating receptor. This would parallel
Toll-7 in flies, which is found at the cell surface where it binds viral particles. Indeed, the
critical role for plasma membrane TLRs in antimicrobial autophagy is also supported by
recent findings that TLR2 is required for Listeria monocytogenes-induced autophagy in
mammalian cells (4).
In addition to revealing a novel requirement for MyD88 in autophagy activation
during viral infection, our study also suggests an important cell-intrinsic role for MyD88 in
host defense against viruses. Viruses can engage TLRs at both the plasma membrane
and within endosomal compartments. The most well-characterized TLRs in antiviral
immunity are the nucleic acid sensing TLRs (TLR3, TLR7/8, TLR9), which detect either
RNA or DNA species and elicit strong IFN-I responses. Interestingly, a number of
studies suggest that viruses can also be recognized by cell surface TLRs such as TLR2
and TLR4, often via interactions with the glycoprotein (a recognition mechanism that is
conserved with Toll-7 recognition of VSV in flies) (9, 67, 152). Only a few reports have
demonstrated a cell-intrinsic requirement for MyD88 in controlling viral replication, such
as in West Nile virus (WNV) infection of macrophages and certain types of neurons
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(201). We propose that MyD88 may have other essential functions in cell-intrinsic
antiviral immunity, such as by controlling autophagy or perhaps other interferonindependent pathways.
Two additional pathways downstream of virus recognition are also conserved
between flies and mammals. Because TRAF6 has been associated with LPS-induced
autophagy, we investigated the requirement for TRAF6 during RVFV infection. Loss of
TRAF6 in mammalian cells or flies resulted in increased viral replication and impaired
autophagy activation, revealing a critical role for TRAF6 in antiviral autophagy against
RVFV infection. Importantly, these data provide the first evidence that Drosophila TRAF6
can restrict pathogen replication in vivo. In both Drosophila and mammalian systems,
RVFV infection also inactivated Akt, suggesting that this PRR-TRAF6 signaling axis
converges on Akt to regulate antiviral autophagy initiation. Thus, taken together, these
data demonstrate deep conservation of anti-RVFV autophagy across species.
To investigate the clinical relevance of our findings, we also examined whether
pharmacological activation of autophagy is a viable therapeutic strategy for treating
RVFV infection. Indeed, autophagy modulation has been proposed as a treatment for
diverse human disorders, including cancer, metabolic abnormalities, neurodegenerative
disease as well as infection. We found that treatment with two autophagy inducers,
rapamycin and SMER28, greatly reduced viral replication in a variety of human and
murine cell types. Most notably, the antiviral effect of these drugs was also observed in
primary mouse hepatocytes and primary rat neurons. As RVFV targeting of hepatocytes
and neurons during natural infection is one of the main causes of morbidity and
mortality, autophagy activation may be a viable strategy for RVFV intervention in
humans and livestock. These findings are consistent with a recent report identifying a
novel autophagy inducing peptide (Tat-Beclin 1), which limits susceptibility in mice to
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several viruses including WNV, SINV and CHKV (193). While the mechanism of host
protection has not been fully elucidated, the pro-survival effects of autophagy rather than
a direct effect on virus growth may be involved because autophagy per se does not
normally restrict the replication of these particular viruses (11, 113, 162, 216). Since
RVFV replication is normally restricted by autophagy, boosting this process may provide
added benefit and make autophagy activation a particularly effective therapeutic strategy
for RVFV infection.
In addition, our study may speak to the importance of cell type in autophagy.
Most studies on infection and immunity have relied on cell lines or macrophages, but
emerging evidence suggests special functions for autophagy in other cell types.
Interestingly, and perhaps importantly, many of the viruses restricted by autophagy infect
neurons, including SINV and HSV-1, as well as RVFV identified in this study. Moreover,
some cells rely more heavily on IFN-I-independent mechanisms to counteract virus
infection. This was clearly shown for dorsal root ganglion neurons, which are less
responsive to IFN-I and use autophagy as a major anti-HSV-1 defense (241). We also
find that autophagy activation limits RVFV replication in hepatocytes, another cell type
with a high basal level of autophagy in which autophagy has not been extensively
studied for its role in antiviral defense. Rather, studies have found that hepatitis C virus
has subverted this pathway, becoming dependent on autophagy for replication (56). It
will be interesting to determine the relative contribution of IFN-I versus autophagy in viral
control in neurons and hepatocytes during RVFV infection and whether other viruses
that target these organs are more susceptible to antiviral autophagy.
In conclusion, we have taken advantage of the simplified system in Drosophila to
discover a conserved role for autophagy genes in restricting RVFV replication in
mammals. Toll receptors or signaling molecules downstream of TLRs (i.e. MyD88) are
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necessary for RVFV-induced autophagy in both flies and mammalian cells, further
defining the ancient nature of the antiviral autophagy response. Importantly, these
findings help elucidate the mechanism by which autophagy is triggered during viral
infection and add to the mounting evidence that autophagy activation may be beneficial
for treatments of infections and other diseases.
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Figure 9. Toll-7 restricts RVFV infection in adult flies.
A. Survival of RVFV-infected Toll-7 mutant flies (Toll-7 null: Df(2R)BSC22/Toll-7g1-5) or
sibling control flies (Toll-7 heterozygous: Df(2R)BSC22/+, +/Toll-7g1-5). Mean±SE;
p<0.001, log-rank test. B. Viral titers from RVFV-infected Toll-7 mutant or control flies as
measured by plaque assay 3 dpi. Mean±SD, *p<0.05, Student’s t-test. C. Toll-7 mutant
or control flies were challenged with RVFV and viral RNA was monitored by Northern
blot. D. Fold increase in RVFV S segment genomic RNA and N mRNA 6 dpi normalized
to Df(2R)BSC22/+ control. Mean±SE, *p<0.01, Student’s t-test. E. Survival of RVFVinfected Toll-7-overexpressing flies (hs-Gal4> UAS-Toll-7) and control flies (hs-Gal4> +).
Mean±SE. F. Representative Northern blot for RVFV RNA from Toll-7-overexpressing
flies or control flies 6 dpi. G. Fold decrease in RVFV N mRNA levels 6 dpi for the
indicated genotypes. Mean±SE; *p<0.05, Student’s t-test. H. Biotinylated RVFV virions
or IgG were incubated with Drosophila cells at 4°C for one hour and subsequently
precipitated with streptavidin from cell lysates. Bound proteins were monitored by
immunoblot. All data are representative of three independent experiments.
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Figure 10. Toll-7 is required for RVFV-induced autophagy.
A. Wild-type flies (w118) were infected with RVFV and Atg8 expression was monitored by
immunoblot 3 dpi. B. Representative fat body images from uninfected or RVFVchallenged flies expressing GFP-Atg8a (YP1-Gal4> UAS-GFP-Atg8a). The arrow
indicates a fat body cell with GFP-Atg8a puncta in an infected animal. Scale bar, 10 µM.
C. Percent of fat body cells containing GFP-Atg8a puncta from uninfected or RVFVinfected flies. Mean±SD, **p<0.01, Student’s t-test. D. Survival of RVFV-infected Atg18silenced flies (Act-Gal4> UAS-Atg18 IR) or control flies (+> UAS-Atg18 IR). Mean±SE for
three independent experiments; p<0.001, log-rank test. E. Representative Northern blot
of RVFV RNA from flies depleted of Atg18 in the fat body (YP1-Gal4> Atg18 IR) or
control flies 6 dpi. F. Fold increase in RVFV RNA in Atg18-silenced flies. Mean±SE. G.
Atg8 immunoblot from uninfected or RVFV-infected Toll-7 mutant flies or control flies. H.
Atg8 immunoblot from uninfected or RVFV-challenged Toll-7-overexpressing or control
flies. I. Flies (hs> +) were challenged with insulin and either RVFV or PBS, and Akt
activity was monitored by immunoblot 3 dpi. J. Northern blot for RVFV RNA from flies
fed either rapamycin (100 µM) (RAPA) or vehicle control (ethanol, ETOH) 6 dpi. K. Fold
decrease in viral RNA with rapamycin treatment as quantified by Northern blot analysis.
Mean±SE; *p<0.05, Student’s t-test. L. Northern blot for RVFV RNA 6 dpi from Toll-7
mutant flies or sibling control flies fed either rapamycin or ethanol. All data are
representative of at least three independent experiments.
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Figure 11. Atg5 limits RVFV replication in mammalian cells.
A. WT and Atg5-/- MEFs were treated with rapamycin (RAPA, 1 µM) or chloroquine
(CHQ, 20 µM) for six hours and monitored for LC3 expression by immunoblot. B,C.
RVFV (B) or VSV (C) was titered on WT or ATG5-/- MEFs by plaque assay. Mean±SD;
*p<0.05, Student’s t-test D. Representative immunofluorescence images of WT or Atg5-/MEFs infected with RVFV (16 hours) or VSV (12 hours). E,F. Quantification of the
percentage of RVFV-infected (E) or VSV-infected (F) cells normalized to the WT control.
Mean±SD; *p<0.05, Student’s t-test. G. Immunoblot for LC3 expression in uninfected or
RVFV-infected WT and Atg5-/- MEFs 8 hpi. H. WT or Atg5-/- MEFs were infected with
RVFV for 12 hours and p62 expression was assessed by immunoblot. I. WT MEFs were
incubated with UV-inactivated RVFV for 16 hours and p62 expression was monitored by
immunoblot. J. Immunoblot for phospho-Akt and total Akt from WT MEFs incubated with
UV-inactivated RVFV for 8 hours. All data are representative of three independent
experiments.
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Figure 12. Autophagy genes restrict RVFV infection in human cells.
A. Representative image of human U2OS cells stably expressing a mCherry-GFP-LC3
reporter either mock infected or infected with RVFV (MOI 10) at 18 hpi. mCherry puncta
represent total autophagosomes. B. Quantification of the average mCherry-positive LC3
puncta per cell for three independent experiments; Mean±SE; *p<0.05, Student’s t-test.
C. U2OS cells were infected with RVFV at the indicated MOI and p62 expression was
assessed by immunoblot 18 hpi. D. Average p62 protein levels normalized to tubulin
from uninfected or RVFV-infected U2OS cells for three independent experiments.
Mean±SE; *p<0.05, Student’s t-test. E. Representative immunoblot from U2OS cells
transfected with the indicated siRNAs three days post-transfection. F,G. Northern blot for
RVFV RNA from U2OS cells transfected with the indicated siRNAs and infected with
RVFV for 16 hours. H. Average fold increase in RVFV RNA from U2OS cells transfected
with the indicated siRNAs. Mean±SE for three independent experiments; *p<0.05,
Student’s t-test.
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Figure 13. MyD88 restricts RVFV replication and regulates antiviral autophagy in
mammalian cells.
A. Immunoblot of MyD88 and TRIF from U2OS cells transfected with the indicated
siRNAs 3 days post-transfection. B. Representative immunofluorescence images of
U2OS cells transfected with the indicated siRNAs and infected with RVFV at 16 hpi (MOI
0.1). C. Quantification of the percent of infected cells for 3 independent experiments.
Mean ±SD, *p<0.05, Student’s t-test. D. Northern blot for RVFV RNA from U2OS cells
transfected with MyD88-specific siRNA or control siRNA and infected with RVFV (MOI
0.3) 16 hpi. E. Quantification of RVFV RNA from (D) for 3 independent experiments.
Mean±SE, *p<0.05, Student’s t-test. F. Plaque assays with RVFV were performed on
MyD88-/- or WT MEFs. G. Representative images of siRNA-transfected U2OS cells
expressing a mCherry-GFP-LC3 reporter and left uninfected or infected with RVFV (MOI
10). mCherry puncta are shown. H. Quantification of the percentage of cells with at least
5 LC3-positive puncta per cell. Mean±SE for 3 independent experiments; *p<0.05
compared to siCon RVFV-infected cells, Student’s t-test. I. LC3 immunoblot of MyD88-/or WT MEFs infected with RVFV 12 hpi. J. p62 immunoblot of MyD88-/- or WT MEFs
infected with RVFV 16 hpi. All data are representative of three independent experiments.
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Figure 14. TRAF6 regulates antiviral autophagy against RVFV infection.
A. Immunoblot for RVFV Gn and TRAF6 from siRNA-transfected U2OS infected with
RVFV 16 hpi. B. Representative RNA blot from RVFV-infected U2OS transfected with
control or TRAF6-specific siRNA and infected with RVFV 16 hpi. C. Fold increase in
RVFV S segment RNA quantified by Northern blot. Mean±SE for three independent
experiments; *p<0.05, Student’s t-test. D. Average percentage of cells with at least 5
LC3 puncta from mCherry-GFP-LC3 U2OS cells transfected with the indicated siRNAs
and incubated with UV-inactivated RVFV for 12 hours. Mean±SE for three independent
experiments; *p<0.05 compared to siCon UV-RVFV treated cells, Student’s t-test. E.
Representative RNA blot form RVFV-infected dTraf6-/- flies (dTraf6Ex1/dTraf6Ex1) or
heterozygous sibling control flies 6 dpi. F. Fold increase in RVFV S segment RNA
quantified by Northern blot. Mean±SE for three independent experiments; *p<0.05,
Student’s t-test. G. Atg8 protein expression was assessed by immunoblot from RVFVinfected flies 3 dpi.
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Figure 15. Autophagy-activating drugs protect against RVFV infection in
mammalian cells. A. MEFs were pretreated with rapamycin (1 µM), SMER28 (50 µM)
or vehicle control (ethanol) for one hour and infected with RVFV (MOI 1). Infection was
monitored by immunofluorescence. B,C. Dose response curve for RVFV infection of
MEFs treated with the indicated concentrations of rapamycin (B) or SMER28 (C).
Percent infection was normalized to vehicle control-treated cells. D. Representative
immunofluorescence image of U2OS cells pretreated with rapamycin or SMER28 and
infected with RVFV at 16 hpi. E,F. Dose response curve for RVFV infection of U2OS
treated with the indicated concentrations of rapamycin (E) or SMER28 (F). G,H. Dose
response curve for VSV and SINV infection of U2OS treated with the indicated
concentrations of rapamycin (G) or SMER28 (H). Data show mean±SE for three
independent experiments.
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Figure 16. Autophagy inducers inhibit RVFV infection in primary mouse hepatocytes and
rat neurons.
A. Primary mouse hepatocytes were infected with RVFV (MOI 5). p62 and LC3 protein
expression was assessed by immunoblot. Data are representative of 2 independent experiments.
B. RVFV RNA levels from primary mouse hepatocytes pretreated with SMER28 or rapamycin and
infected with RVFV (MOI 1) for 20 hours as determined by qRT-PCR. Data are representative of
2 independent experiments. C. Isg56 mRNA expression quantified by qRT-PCR from RVFVinfected mouse hepatocytes treated with the indicated drugs or vehicle control at 20 hpi. D.
Primary rat neuronal cultures were infected with RVFV for the indicated times (MOI 1) or treated
with rapamycin (1 µM) or SMER28 (50 µM) for 16 hours. Immunoblot analysis of LC3 and p62
expression is shown. Data are representative of two independent experiments. E. Primary rat
neuronal cultures were pretreated with SMER28 or vehicle control for one hour and infected with
RVFV (MOI 0.1) for 22 hours. Infection was assessed by immunofluorescence. F. Fold decrease
in the percent of RVFV-infected rat neuronal cells with SMER28 treatment. Mean±SE for 3
independent experiments; *p<0.05, Student’s t-test. G. Immunofluorescence of RVFV and
neurons (MAP2-positive cells) from RVFV-infected neuronal cultures pretreated with SMER28 or
vehicle control showing preferential protection of neurons with SMER28 treatment. H. RVFV RNA
was quantified by qRT-PCR from infected cells pretreated with SMER28 or rapamycin at 22 hpi.
Mean±SE for 3 independent experiments normalized to ETOH control; *p<0.05, Student’s t-test.
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V. CONCLUDING REMARKS
Insect-borne viruses are a subset of emerging and reemerging pathogens that
cause devastating disease in both humans and agriculturally important animals.
Unfortunately, however, there is a paucity of effective therapeutics and vaccines to
combat arboviral infection. As the first line of defense against viruses, the innate immune
system plays an essential role in controlling arboviral replication and pathogenesis.
Therefore, a better understanding of the innate antiviral response against these viruses
in both mammals and the insect vector may facilitate the development of novel
therapeutic strategies. To address this question, I took advantage of Drosophila to
investigate the regulation of an essential antiviral response in flies and applied these
findings to mammalian systems, thereby revealing an evolutionarily conserved antiviral
autophagy pathway that may be amenable to therapeutic intervention.
We previously found that autophagy, an ancient biological pathway that degrades
cytoplasmic material, is a critical component of the Drosophila innate immune arsenal
against VSV infection (188). While VSV infection activated autophagy in cells and in
flies, the mechanism by which autophagy was triggered remained unclear. In particular,
the glycoprotein VSV-G was sufficient to elicit autophagy, suggesting that flies encode
an unknown PRR that recognizes VSV-G to initiate an antiviral autophagic program.
Using a targeted RNAi screen of the Drosophila Toll receptors, which we hypothesized
as candidate PRRs for VSV, we discovered that Toll-7 is necessary for restricting viral
replication in vitro. Furthermore, loss of Toll-7 in adult flies increased VSV replication
and mortality, showing that Toll-7 similarly controls infection in vivo. Toll-7 was also
required both in cells and in flies to elicit autophagy after VSV challenge. Therefore, Toll7 is the missing link between VSV recognition and the activation of antiviral autophagy in
Drosophila. Through an in vivo screen of Toll receptor mutant flies, I next discovered that
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Toll-7 is also necessary to activate antiviral autophagy during infection with RVFV, a
medically relevant arboviral pathogen that causes disease in humans and livestock.
Quite remarkably, the role of autophagy in restricting RVFV but not VSV replication was
conserved in mouse and human cells. RVFV is consequently the first viral pathogen that
has been shown to be controlled by autophagy in both Drosophila and mammalian
systems. Taken together, our data have uncovered an evolutionarily conserved function
for autophagy in antiviral defense from insects to humans.
The importance of the Toll signaling pathway has been appreciated for over two
decades, and the immune functions of the mammalian TLRs have been extensively
studied (203). Somewhat surprisingly, however, the biological roles of the Drosophila
Toll receptors (besides the canonical gene Toll) have remained mysterious. While some
Toll receptors such as Toll-2, Toll-5 and Toll-9 can induce AMP production upon ectopic
expression in vitro (207, 227), their immune functions in vivo have been less clear (128,
153), and only Toll has been conclusively demonstrated to mediate pathogen resistance
in previous studies (16, 122). Mammalian TLRs are not thought to be required for
development unlike some Drosophila Toll receptors such as Toll, which regulates dorsalventral polarity and embryonic segmentation (5). In comparison to mammalian TLRs that
directly bind PAMPs, Drosophila Toll indirectly senses pathogens by binding a host
cytokine activated upon infection (224). Moreover, with the exception of Toll-9, the
Drosophila Tolls and the mammalian TLRs cluster separately by phylogenetic analysis
(124). For these reasons, it has been proposed that immune functions for TLRs arose
separately in flies and mammals (124). Nevertheless, the requirement for the Drosophila
Toll receptors in viral infection and autophagy had not been previously assessed. We
found that Toll-7 is a PRR that binds viral particles to initiate antiviral autophagy,
demonstrating a conserved role for Toll receptors in immunity and pathogen recognition.
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Our data suggest that despite noted differences between Drosophila Tolls and
mammalian TLRs, they are functionally more similar than previously appreciated,
providing support that Toll receptors evolved for antimicrobial defense. Additional studies
with other types of pathogens may unveil other hidden immune functions for these
receptors. Moreover, we found that Toll-7 regulates a deeply conserved biological
process—autophagy—that is found from yeast to humans, and autophagy restricts viral
infection, especially RVFV, in both flies and mammals. These data suggest that the Toll
receptor-autophagy is perhaps one of the most ancient innate antimicrobial responses.
While autophagy gene deficiency increases susceptibility to VSV and RVFV
infection in flies, as well as RVFV infection in mammalian cells, the precise mechanism
by which autophagy is antimicrobial is unknown. Indeed, the identification of specific
restriction mechanisms remains an outstanding question in the antiviral autophagy field.
Whereas intracellular bacteria can be readily identified within autophagosomes,
suggesting that intact bacteria are degraded through the lysosomal pathway, viral
targets for autophagy have remained largely elusive. Two general possibilities exist for
the antiviral autophagy restriction mechanism against VSV and RVFV infection:
autophagy may act directly by degrading virions or virus-derived molecules, or
autophagy may act indirectly by modulating a host pathway that intersects with viral
replication. For example, viral proteins that are necessary for viral RNA synthesis, such
as the viral polymerase or the nucleocapsid protein, may be recognized upon entry or
early during infection and trafficked to autophagosomes for elimination. This direct
mechanism would have a substantial impact because proteins such as the VSV
polymerase are low in abundance and therefore limiting for viral replication. On the other
hand, some studies have proposed indirect effects of autophagy inhibition on viral
replication through its modulation of cell death pathways. For instance, in CHIKV
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infection, autophagy may delay caspase-dependent apoptosis to restrict virus growth
and limit lethality (96). Other cellular processes such as mRNA decapping, which occurs
in cytoplasmic RNA-protein granules known as processing bodies (p bodies), restrict
RVFV infection in flies (77). Intriguingly, recent studies showed that autophagy regulates
the clearance of stress granules (22), which are closely related to p bodies, suggesting
that perhaps autophagic regulation of p bodies and mRNA decapping may have an
indirect impact on RVFV replication. Additional experiments to decipher the specific
stage in the viral life cycle targeted by autophagy during VSV and RVFV infection may
reveal important insights into the virus restriction mechanism. Moreover, the
identification of specific viral proteins that co-localize with autophagosomes and bind
autophagy proteins like LC3 would provide support for direct antiviral activity.
Traditionally, autophagy has been thought of as a nonselective, bulk degradative
pathway. In certain contexts, however, autophagy can be selectively activated to
degrade specific cytoplasmic targets, such as the directed recycling of damaged
organelles (111). This non-random form of autophagy is known as “selective autophagy.”
Bacterial capture in the cytoplasm relies on recognition by autophagic cargo receptors,
which also interact simultaneously with core autophagy proteins such as LC3 to deliver
pathogens to nascent autophagosomes. For example, S. Typhimurium is recognized by
the autophagy receptors p62, NDP52 and optineurin (209, 226, 246). Other studies have
demonstrated a role for p62 and NDP52 in L. monocytogenes and Shigella flexneri
recognition, as well as NDP52 in Streptococci recognition (149, 217, 242). SINV capsids
are also degraded via p62, although this clearance primarily impacts neuronal
pathogenesis and does not generally limit viral replication (162). Most known autophagy
cargo receptors detect polyubiquitin tags that are deposited on invading bacteria, and
several E3 ubiquitin ligases including LRSAM1 and parkin promote antibacterial
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autophagy and the recruitment of autophagy receptors (83, 137). Additionally, other
danger signals such as diacylglycerol or host glycans exposed on damaged bacteriacontaining vesicles (via galectin 8) are also recognized (186, 210).
While the role of autophagy adapters in bacterial infection has been extensively
dissected, the function of these receptors in antiviral autophagy remains poorly
understood. SINV infection has been studied as a model of selective autophagy,
revealing additional selective autophagy factors such as the E3 ubiquitin ligase SMURF1
(164). Nevertheless, SINV replication is not augmented by the loss of autophagy, and
therefore it is still not known whether selective autophagy receptors are directly involved
in facilitating virus degradation to control replication. As RVFV infection is restricted by
autophagy in multiple cell types and organisms, studying this virus may unveil critical
insights into our understanding of selective antiviral autophagy. Future studies should
determine if known autophagy adapters control RVFV replication, and if so, whether
RVFV targets physically associate with these adapters. Given the important role of
ubiquitination in selective autophagy, additional experiments could determine if RVFV
targets are ubiquitinated and if any known E3 ubiquitin ligases are essential for this
process.
Furthermore, the function of selective autophagy in Drosophila antimicrobial
defense has not been assessed. Notably, Drosophila encodes a homolog of mammalian
p62 (known as ref(2)p), which has an LC3-interacting motif and localizes to protein
aggregates in autophagy-defective flies and in neurodegenerative disease models (155).
While ref(2)p has not formally been shown to control antimicrobial autophagy, some data
suggest that it acts as a viral restriction factor, as flies in wild populations carrying certain
ref(2)p alleles are less permissive to sigma virus, a natural Drosophila pathogen related
to VSV (27). Intriguingly, ref(2)p physically interacts with sigma virus proteins (229),
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raising the possibility that this recognition may promote autophagic clearance of the
virus. Given the similarities between sigma virus and VSV, perhaps p62-dependent
selective autophagy may play a role in VSV restriction by targeting capsids or other viral
proteins. Because antiviral autophagy against RVFV infection is conserved between flies
and humans, clearance of RVFV may also depend on conserved selective autophagy
adapters. Therefore, it would be interesting to determine if ref(2)p deficiency enhances
susceptibility to RVFV infection, as well as screen for other candidate selective
autophagy factors that impact viral infection.
Through co-immunoprecipitation studies, we determined that Toll-7 functions as
a bona fide PRR for virus particles, which is a novel finding for the Drosophila Toll
receptor family. While Toll and its downstream signaling pathway mediate resistance to
Gram-positive bacterial and fungal infection in flies, Toll is not a PRR akin to its
mammalian counterparts that directly recognize pathogen-derived ligands. Rather, Toll
functions indirectly by binding a host cytokine spätzle that is processed upon infection to
its active form (224). Other Tolls have also been suggested to function as cytokine
receptors: Toll-8 mutants phenocopy Spätzle2/DNT1 mutant flies with regard to AMP
expression (2), and the neurotrophins DNT1 and DNT2 have been proposed to bind Toll6 and Toll-7 (139). By precipitating purified VSV and RVFV virions from the surface of
Drosophila cells, we found that we could pull-down Toll-7, suggesting that Toll-7
interacts with viral particles at the plasma membrane. This interaction was specific for
Toll-7, as we did not co-immunoprecipitate the canonical Drosophila Toll receptor, Toll.
Thus, these studies provide the first evidence that Drosophila Toll receptors can function
as PRRs and evolved to detect pathogens directly. Additional studies, such as the
expression of purified Toll-7 ectodomain, will help determine whether Toll-7 alone is
sufficient for pathogen detection or if other protein cofactors are involved.
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While we did not directly test the exact ligand on VSV and RVFV through binding
assays, our data suggest that the viral glycoproteins may be the features that are
sensed by Toll-7. First, we previously showed that VSV-G but not viral RNA or RNP
complexes triggers autophagy in vitro. Second, surface-bound VSV particles precipitate
Toll-7 from Drosophila cells. Third, pre-bound RVFV virions, which should similarly only
have glycoproteins available for binding, also pulled down Toll-7. We were unfortunately
not able to test if the RVFV glycoproteins alone can activate autophagy or interact
directly with Toll-7 as RVFV glycoprotein heterodimers have not successfully been
purified. However, our data suggest that these glycoproteins are the most likely
candidate. Interestingly, several mammalian TLRs also recognize viral glycoproteins,
indicating that the detection of viral glycoproteins by surface PRRs may be a common
biological theme across species. It remains unclear how Toll-7 may specifically
recognize VSV and RVFV glycoproteins. VSV-G is trimeric and forms spikes that
protrude from the virion surface (173), while RVFV has two glycoproteins (Gn/Gc) that
form heterodimers (177). As homology between the two glycoproteins is not obvious,
future structural studies may reveal molecular details of how Toll-7 recognizes its
ligands. An attractive hypothesis is that perhaps particular glycosylation patterns serve
as a recognition motif for Toll-7.
In addition to activating autophagy in flies via Toll-7, RVFV likely elicits antiviral
autophagy in mammals through a PRR. UV-inactivated RVFV triggered autophagy in
MEFs and human U2OS cells, indicating that viral replication is dispensable for RVFVactivated autophagy. We also found that the TIR adapter MyD88, which functions
downstream of several TLRs, is critical for restricting RVFV replication through antiviral
autophagy. The specific TLR that detects RVFV must be further clarified. The PRR for
RVFV most likely is MyD88-dependent (TLR1/2, TLR2/6, TLR4, TLR5, TLR2/6, TLR7,
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TLR9) and resides at the cell surface (TLR1/2, TLR4, TLR5, TLR2/6). TLR2 and TLR4
are the most likely candidates because they are surface expressed, they have been
shown to recognize viral glycoproteins and they have been linked to autophagy
activation in response to agonists (4, 24, 67, 192, 235). Hence, additional experiments
should determine if these TLRs control RVFV infection and promote anti-RVFV
autophagy.
Once the pathogen is recognized, additional signaling events must link PRR
ligation to the initiation of autophagy. Several studies have investigated the requirements
for established signaling molecules in TLR-responsive autophagy, but these studies
typically use model TLR ligands rather than live infection models (50). Moreover, some
studies have produced contradictory results, such as the role of MyD88 in TLR4-induced
autophagy (190, 235). Finally, while some progress has been made on the signaling
molecules that contribute to antibacterial autophagy (i.e. MyD88 in intestinal epithelial
cells during S. Typhimurium infection, the adapter STING and the kinase TBK-1 in M.
tuberculosis infection and RIP2/ERK signaling in L. monocytogenes infection) (4, 13,
167, 221), little is known regarding signaling events upstream of autophagy in viral
infection.
To determine the role of canonical Drosophila immune signaling pathways (Toll,
IMD, Jak-Stat) in antiviral autophagy, we monitored the susceptibility of mutant flies or
assessed antimicrobial gene induction after VSV infection. Interestingly, flies deficient in
the Toll signaling adapter MyD88 or transcription factor Dif showed no increase in VSV
replication, suggesting that the Toll pathway is dispensable for VSV restriction. We also
observed no upregulation of antimicrobial genes associated with the IMD or Jak-Stat
pathways (Dipt, vir-1). Taken together, these data imply that antiviral autophagy
proceeds independently of known immune signaling pathways in the fly, similar to L.
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monocytogenes-activated autophagy that also does not require IMD or Toll signaling
(238).
In contrast, our data suggest that the deeply conserved nutrient signaling
pathway regulates antiviral autophagy across species. Under nutrient-replete conditions,
the PI3K-Akt-Tor pathway normally inhibits autophagy; however, during starvation, this
block is alleviated to facilitate autophagy initiation (133). We previously observed that
VSV infection attenuates Akt activation in vivo (as shown by decreased Akt
phosphorylation), and that genetic modulation of Akt activation impacts VSV replication.
RVFV infection similarly dampens Akt phosphorylation in flies, and quite strikingly, this
response is found in RVFV-challenged mammalian cells. Importantly, the effect on Akt
signaling cannot be simply explained by the excessive metabolic demands of ongoing
viral replication, as UV-inactivated RVFV also led to decreased Akt phosphorylation.
These findings suggest that both Drosophila and mammalian antiviral autophagy
converge on the attenuation of the Akt pathway as a trigger.
While MyD88 seems to be dispensable for antiviral autophagy in flies, we
identified a requirement for mammalian MyD88 in RVFV-elicited autophagy. Indeed,
silencing of MyD88 but not TRIF in U2OS cells increased RVFV replication, and MyD88/-

MEFs also produced elevated RVFV titers. MyD88-depleted U2OS cells and MyD88-/-

MEFs also exhibit defective autophagy activation in response to RVFV infection. Why
mammalian MyD88 but not Drosophila MyD88 promotes antiviral autophagy remains
unclear, but notably, there are functional differences between the two molecules. For
example, whereas MyD88 is normally cytosolic at steady state in mammalian cells,
dMyD88 is present at the plasma membrane even without Toll stimulation (138).
Consequently, it has been argued that dMyD88 functions as a “sorting adapter” involved
in recruiting other signaling molecules rather than a “signaling adapter.” Furthermore, the
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intracellular proteins that bind Toll-7 to transmit signals from the cell surface are not
known. Like other members of the Toll receptor family, Toll-7 contains a cytoplasmic TIR
domain that can mediate protein-protein interactions. In addition to MyD88, flies have
another highly conserved TIR adapter known as Ect4 (SARM in mammals), and some
studies propose that Toll-8 signals through Ect4, although directly links between the two
molecules are lacking (2). Therefore, it would be interesting to test if Ect4 restricts VSV
or RVFV infection in flies. The Toll-7 intracellular domain also contains additional amino
acids besides the TIR domain, including a polyglutamine stretch, and so it may also
signal through other proximal molecules besides TIR adapters.
Though the TIR adapter that regulates antiviral autophagy may not be the same
in flies as in mammalian cells, we have discovered a shared requirement for the E3
ubiquitin ligase TRAF6. Because TRAF6 functions downstream of several TLRs and was
linked to TLR4-mediated autophagy (191), we tested its role during RVFV infection of
flies and mammalian cells. Flies deficient in dTraf6 showed significantly increased viral
RNA levels and impaired autophagy activation during RVFV infection, demonstrating
that dTraf6 regulates antiviral autophagy. Importantly, these data provide the first
evidence that dTraf6 controls pathogen replication, as previous studies have only
assessed cell biological readouts such as AMP production (30). Silencing of TRAF6 in
human cells similarly increased viral replication and attenuated anti-RVFV autophagy.
Combined with our findings that RVFV infection dampens Akt activation in both systems,
these data suggest that a conserved signaling pathway acts downstream of PRR
stimulation to regulate antiviral autophagy. In addition to its role in TLR signaling,
mammalian TRAF6 has also been implicated in starvation-induced autophagy (154). As
such, TRAF6 and Akt may function as conserved signaling hubs that coordinate both
nutritional and immune signals to regulate autophagy.
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TRAF6 plays a critical role in mediating antiviral autophagy, but the specific
mechanism by which it regulates autophagy during infection remains to be further
defined. In fact, there is evidence that TRAF6 can directly interact with core autophagy
proteins and indirectly impact autophagy by modulating upstream signaling pathways.
For example, one study showed that TRAF6 binds Beclin 1 and mediates K63-linked
ubiquitination, which positively regulated autophagy in response to TLR4 stimulation
(191). TRAF6 has also been shown to interact with p62 and catalyze K63 ubiquitination
of mTor, which inhibited autophagy in response to amino acid supplementation (130). In
other settings, TRAF6 interacted with AMBRA1 and catalyzed K63 ubiquitination of
ULK1 to promote autophagy (154). Finally, TRAF6 has been shown to both positively
and negatively regulate Akt activation (166, 237), which also controls autophagy
activation and was modulated by RVFV infection in our studies. Consequently, there are
multiple steps of the autophagy pathway with which TRAF6 may intersect. Future
studies should determine if TRAF6 directly or indirectly regulates autophagy and if it
controls the ubiquitination of targets during viral infection.
To complement our loss-of-function studies, we also examined whether drugs
that activate autophagy affect viral infection. In flies, we found that the canonical
autophagy inducer rapamycin reduces RVFV replication in vivo and bypasses the
requirement for Toll-7. Paralleling these results, rapamycin and SMER28 (a recently
described autophagy activator) inhibited RVFV infection in MEFs and human U2OS
cells, as well as in primary rat neurons and primary mouse hepatocytes. Thus, our data
demonstrate that autophagy activation could be a potential therapeutic target to treat
RVFV infection, for which there is a paucity of effective drugs or vaccines. Our results in
flies also suggest that autophagy modulation may be a possible strategy for controlling
virus transmission in the insect vector. Finally, these beneficial effects of autophagy
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modulation in RVFV infection are consistent with other reports showing that therapeutic
autophagy activation limits viral pathogenesis in mice (193). Additional experiments
should be performed in mammalian models in vivo as well as with wild-type strains of
RVFV to determine if autophagy activation to treat RVFV infection is viable clinically.
In exploiting the autophagy pathway to combat viruses such as RVFV, it will be
essential to develop more specific autophagy modifiers, as all known drugs have
autophagy-independent effects. For example, rapamycin is approved for use in humans
but has severe immunosuppressive effects, making it an attractive drug to prevent organ
transplant rejection but perhaps not to block viral pathogenesis in humans. In contrast to
rapamycin, the off-target effects of SMER28 have not been assessed, although it
appears to act independently of mTor (182). Additional studies should characterize the
pharmacodynamics and pharmacokinetics of SMER28 so that it can be tested in vivo
mammalian models of RVFV infection. Another important consideration is the target
tissue of autophagy modulating therapy, as mounting evidence indicates that autophagy
has specific roles depending on the cellular context. For example, autophagy played a
critical role in restricting HSV-I replication in dorsal root ganglionic neurons but was
dispensable in epithelial cells (241). As a consequence, autophagy may be more
effective in treating certain types of virus-related clinical manifestations, such as
encephalitis since we observed a particularly robust effect of SMER28 in RVFV infection
of neurons. Moreover, autophagy has many important functions in basal cellular
metabolism and energy homeostasis, as well as specific immune regulatory roles, such
as the negative regulation of Type I interferon pathways and inflammasome signaling
(117, 133, 205). Therefore, the potential off-target consequences of combating viral
infection with autophagy-inducing drugs must also be considered. A better
understanding of selective autophagy mechanisms that help eliminate RVFV and other
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viruses may provide insights into more specific autophagy modulators that can treat
infection. In this manner, perhaps pathogens could be directly recruited to
autophagosomes, such as by activating autophagy adapters or ubiquitin ligases that
specifically recognize pathogens or mark them for degradation, while leaving other
functions of autophagy unperturbed.
In conclusion, I have taken advantage of the Drosophila model system to identify
an evolutionarily conserved antiviral pathway shared between flies and mammals. These
studies have provided novel insights into the mechanisms regulating antiviral autophagy,
in particular the role of pattern recognition, and shown that the PRR-autophagy axis is
necessary for viral resistance in vivo. Moreover, I have found a critical role for autophagy
in restricting RVFV infection and discovered additional upstream signaling pathways that
may regulate this response. Collectively, these studies may have important implications
in developing new strategies for combating infection with RVFV and other arboviruses in
the mammalian host, as well as the insect vector.
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VII. APPENDIX: SUPPLEMENTARY FIGURES

Figure S1. Knockdown of Tolls in cell culture.
Knockdown of each Toll receptor is shown using RT-PCR and compared to the
housekeeping control Rp49.
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Figure S2. Toll-7 is antiviral in adult flies.
A. Knockdown of each Toll verified by RT-PCR. B. Toll-7 depleted flies or sibling
controls expressing an independent RNAi allele of Toll-7 (#2) were infected with VSV
and viral replication was monitored by Northern blot 6 d.p.i. Average fold change in
infection ±SD for 3 independent experiments; *p <0.05, Student’s t-test. C. Northern blot
for viral RNA from the indicated genotypes. D. Flies expressing heat shock-driven Toll-7
dsRNA (hs-Gal4> Toll-7 IR) or control flies (hs-Gal4> +) were infected with VSV and
monitored for viral replication at 6 d.p.i. by RNA blot. E. Flies either heterozygous or
homozygous mutant for Toll-2 were challenged with VSV, and viral replication was
monitored by Northern blot at 6 d.p.i. Mean±SD for three experiments. F. Diagram of
Toll-7 gene indicating the deletion. Closed arrows indicate positions of primers used for
DNA genotyping, and open arrows represent primers used for RT-PCR analysis. G.
Genotyping of Toll-7 mutant flies compared to control flies. Deletion results in a product
that can be amplified by PCR. H. RT-PCR analysis of Toll-7 mRNA from control or Toll-7
mutant flies. I. RNA blot for viral RNA from VSV-infected Toll-7 mutants
(Df(2R)BSC22/Toll-7g1-5) or sibling controls (Df(2R)BSC22/+ and +/Toll-7g1-5).
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Figure S3. Characterization of Toll-7 antibody.
Protein lysates from transgenic flies overexpressing Toll-7 (hs-Gal4> UAS-Toll-7) or
control flies (hs-Gal4> +) were probed for Toll-7 and a cellular control (tubulin).
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Figure S4. VSV-induced GFP-LC3 puncta are Toll-7-dependent.
Puncta were counted for at least 40 cells from each treatment in three independent
experiments and presented as a notched box plot. The horizontal dark line represents
the median for each category. The box represents the interquartile range, and the
whiskers encompass the most extreme data values. The notches represent a confidence
interval for the median, and non-overlapping notches indicate different medians at the
5% significance level. There is a significant difference between uninfected and infected
or starved. Depletion of Toll-7 does not significantly affect the starvation-induced puncta
but does block VSV-induced puncta.
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Figure S5. Antiviral autophagy does not require MyD88-dependent signaling.
MyD88-deficient flies were uninfected or challenged with VSV and analyzed for Atg8
expression on day 2 post infection by immunoblot.
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Figure S6. Toll-7 antiviral activity is specific for RVFV in vivo.
A. Survival of Toll-8 mutant flies (Df(3L)Brd15/Toll-859) or sibling controls either
uninfected or infected with RVFV. B. RVFV titers from Toll-8 mutant or control flies 6 dpi.
C. RNA blot for RVFV RNA from infected Toll-8 mutant or control flies 6 dpi. D. Northern
blot quantification of RVFV RNA from infected Toll mutant flies (Tl9QRE/Tlr444) or control
flies 6 dpi. E. Viral titers from RVFV-infected Toll-2 mutant flies (Df/18w Δ7-35) or control
flies. F. Viral titers from RVFV-infected Toll-6 mutant (Toll-7ex70/Toll-6ex70) or sibling
controls 6 dpi for two independent experiments. G. RVFV titers from Toll-9 mutant flies
(Toll-9rv17/Toll-9rv17) or sibling controls. H-J. Survival of Toll-7 mutant flies
(Df(2R)BSC22/Toll-7g1-5) or sibling control flies infected with DCV (H), FHV (I) or SINV
(J). K. Immunoblot for DCV capsids from infected Toll-7 mutant or control flies at the
indicated time points post-infection. Data are representative of two independent
experiments. L. Survival of RVFV-infected transgenic flies overexpressing the indicated
Toll receptors or control flies. M. Survival of Toll-7-overexpressing or control flies after
DCV infection. Data are representative of at least three independent experiments
(Mean±SE) unless otherwise noted.
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Figure S7. Autophagy genes restrict RVFV infection in adult flies.
A. Wild-type flies were infected with DCV and Atg8 expression was monitored by
immunoblot 2 dpi. B. Wild-type flies were infected with SINV and Atg8 expression was
assessed by immunoblot 2 dpi. C. RNA blot for RVFV RNA from control flies or flies
depleted of the indicated autophagy genes using a fat body specific driver (YP1-Gal4)
day six post-infection. D. Rapamycin feeding activates autophagy in adult flies as
assessed by Atg8 immunoblot.
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Figure S8. Functional validation of mCherry-GFP-LC3 reporter and autophagy
gene siRNA silencing.
A. Representative images of U2OS cells stably expressing mCherry-GFP-LC3 treated
with rapamycin (RAPA) or chloroquine (CHQ) for six hours. B. Quantification of
mCherry+GFP+ (green) and mCherry+GFP- (red) puncta from and CHQ-treated and UVRVFV treated cells. A representative experiment of >3 independent experiment is
shown. C,D. LC3 immunoblot from U2OS cells transfected with control siRNA or siRNAs
targeting Atg5 (C) or Atg7 (D) after treatment with rapamycin or chloroquine.
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Figure S9. MAVS and TBK1 do not restrict RVFV infection in MEFs.
-/A,B. Plaque assays were performed on WT MEFs or MAVS MEFs to assess viral titers with
-/VSV (A) and RVFV (B). C. Representative immunofluorescence images of WT or MAVS MEFs
infected with VSV or RVFV for 12 hours or 16 hours, respectively. D,E. Quantification of the
-/percentage of infected WT MEFs or MAVS MEFs challenged with either VSV (D) or RVFV (E) at
varying MOI. F. Immunoblot for p62 expression 12 hours post-infection with RVFV. G,H. Viral
+/+
-/titers with VSV (G) or RVFV (H) from infected TBK1 or TBK1 MEFs as assessed by plaque
+/+
assay. I. Representative immunofluorescence images of VSV or RVFV-infected TBK1 or TBK1
/MEFs. J,K. Quantification of (I) for VSV infection (J) or RVFV infection (K). L. p62 immunoblot
+/+
-/from uninfected or RVFV-infected TBK1 and TBK1 MEFs at 12 hpi. M. LC3 immunoblot from
U2OS cells transfected with the indicated siRNAs and left untreated or treated with rapamycin (1
µM) or chloroquine (20µM) for six hours.
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Figure S10. Rapamycin and SMER28 activate autophagy in an Atg5-dependent
manner.
A. Representative images of control siRNA- or Atg5 siRNA-transfected U2OS cells
expressing an mCherry-GFP-LC3 reporter left untreated or treated with rapamycin (1
µM) or SMER28 (50 µM) for 16 hours. mCherry represents total LC3 puncta. B.
Percentage of cells containing at least 5 mCherry-positive LC3 puncta with the indicated
treatment conditions. Quantification for one representative experiment from two
independent experiments is shown.
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